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ABSTRACT
If no reference genome exists, then the generation of a de novo genome assembly
of an organism is necessary because having a reference genome expedites the discoveries
for simple and complex traits. Reference genomes for the domestic dog (Canis lupus
familiaris) and chicken (Gallus gallus) have resulted in the development of single
nucleotide polymorphism (SNP) arrays for use in genome-wide association studies
(GWAS). Next-generation sequencing technologies provide a rapid, increasingly
affordable method for the generation of genome resequencing data.

The first objective of this work was to utilize existing genomic resources to
investigate the genetic basis for traits of the dog and chicken. Episodic falling syndrome
(EFS) is a recessive neurological disease of Cavalier King Charles spaniels. Using SNP
profiles from only 12 individuals, EFS was mapped to chromosome 7; further
experimentation led to the identification of the causative deletion. In a second example,
SNP profiles from 197 German shepherd dogs were generated to identify loci underlying
numerous diseases afflicting the breed, including recessive pituitary dwarfism, and three
complex diseases: degenerative myelopathy, megaesophagus, and pancreatic acinar
atrophy. Lastly, SNP profiles for 60 Araucana chickens were used to identify an
association with the semi-dominant tailless rump (rumpless) phenotype on chromosome
2, as well as the recessive lethal ear-tufts phenotype on chromosome 15. Positional
candidate genes were identified for both traits.

ii

The second objective of this work was to identify loci associated with
dermatomyositis (DM) and to develop resources to facilitate the identification of the
causative mutation. DM is an inflammatory myopathy affecting humans and domestic
dogs, primarily the collie and Shetland sheepdog breeds where painful lesions on the face
and extremities are characteristics. The second objective was accomplished through 1)
assembly of a population of DM-affected and healthy control collies, 2) completion of a
GWAS using SNP profiles generated for this population, and 3) establishment of wholegenome resequencing data from 3 DM-affected collies and 2 healthy controls. Results
revealed a strong association on chromosome 10. Annotation of the collie genome
yielded novel SNPs, structural variants, and selective sweeps, and regions of reduced
heterogeneity surrounding a gene(s) under strong positive selection.
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CHAPTER I
INTRODUCTION
OBJECTIVES OF THE DISSERTATION
My thesis is organized into two broad objectives. In the first I investigated several
simple to complex traits (Chapters II-IV), and the second objective was to identify loci
associated with dermatomyositis (DM) and to develop resources to facilitate the
identification of the causative mutation (Chapters V and VI).

In the first objective I identified the genetic mutation that causes the autosomal
recessive disease, Episodic falling syndrome, in the Cavalier King Charles spaniel
(CKCS) breed (1). This was achieved by 1) using a genome-wide association study
(GWAS) to identify the genetic region associated with the disease, 2) defining a
haplotype present in affected CKCSs, 3) validate candidate genes to identify the
causative mutation, a microdeletion in BCAN, present in affected and carrier CKCS, and
4) developing a genetic test to screen for carriers in the CKCS population (1) (Chapter
II).

Next, I identified loci associated with four diseases (pituitary dwarfism,
degenerative myelopathy, congenital megaesophagous (ME), and pancreatic acinar
atrophy (PAA)) in the German shepherd dog (GSD) (2). The process for all four diseases
was identical; 1) generating single nucleotide polymorphism (SNP) profiles for 197 dogs
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and completing a GWAS for each disease and 2) determining haplotypes for each of the
genetic regions identified. Candidate genes for pituitary dwarfism and degenerative
myelopathy, LHX3and SOD1, were identified, respectively (2). ME and PAA proved to
be complex diseases with multiple regions of association and no single causative
mutation was identified (2) (Chapter III).

In the final part of the first objective, I identified the loci associated with the
tailless and ear-tuft phenotypes in the Araucana chicken (3). This was achieved by
conducting two GWASs using the same population of Araucana chickens and
determining a haplotype for each of the genetic regions identified (3) (Chapter IV).

For the second objective, I studied dermatomyositis (DM), which is an
autoimmune disease with a variable age of onset predominantly affecting collies (4).
Although DM is known to be autosomal dominant with incomplete penetrance the
causative mutation had not been identified (4). Using a GWAS with 27 DM affected and
20 controls collies, I identified a 10.5 Mb candidate region on chromosome 10 associated
with DM. However, the coverage of the SNPs in the haplotype region was insufficient to
discern a narrower region of interest. There are more than 130 identified genes through
conservation of synteny with human chromosome 12 (5). However, only five
homologous genes have been identified in the canine reference genome (Broad
CanFam3.1) within the syntenic region (5) (Chapter V). The SNPs on the Illumina
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CanineHD Infinium BeadChip are based on the most homogenous dog breeds, which
currently excludes the collie (6).
With the long term aim of identifying the causative mutation of DM, I used nextgeneration sequencing (NGS) to resequence five collie dogs to map additional SNPs and
structural variations unique to the collie, which is the final part of my thesis research.
Five phenotypically diverse American collies (three DM and two control) from the
original study were resequenced. Each collie was independently mapped to the canine
reference genome to identify the polymorphisms and regions of reduced heterozygosity
and structural variants unique to the collie breed. This was achieved by 1) generating
2x100 paired-end sequencing data; 2) aligning the remaining concordant paired sequence
reads to the canine reference genome; and 3) identification of SNPS, structural variants
common to all collies, and regions of reduced heterozygosity that could indicate the
presence of selective sweeps in the collie breed.

I identified 9.7 million SNPs and more than 670 thousand structural variants
(insertions, deletions, inversions, tandem repeats, and breakpoints) common to the collie
genome in this cohort. Comparing the newly identified SNPs with the Illumina
CanineHD Infinium BeadChip validated these data. Approximately 36,000 of these SNPs
were predicted missense, splice site, frameshift, stop gained, and stop lost mutations.
Finally, for validation of the structural variants within the resequenced data. I selected the
largest structural variants in the following four classes: deletions, insertions, inversions
and tandem duplications (Chapter VI).

3

THE RELATIONSHIP OF GENETIC VARIATION TO PHENOTYPE
Canine
The dog (Canis lupus familiaris) was the first animal to be domesticated by
humans (7) and it is one of the most phenotypically diverse mammals (8-10). Through
selection, humans have created isolated populations of each dog breed (11). In order for a
dog to be a registered breed, both of its parents must be of the same registered breed. This
is referred to as the pedigree barrier, which maintains the closure of each population
(12,13). The existence of multiple dog breeds, a highly homozygous population unto
themselves, makes the dog a valuable model in understanding the relationships between
genotypes and phenotypes (7). The regions of homozygosity are up to 1 x 106 bp
intrabreed and about 1 x 104 bp interbreed (6). SNPs are located throughout the genome.
Because of the large regions homozygosity within a breed genomic changes exhibit
significant statistical differences allowing for the identification of a large region(s) of
association. The smaller regions of homozygosity between breeds are then used to narrow
the candidate region. Thus, together, the regions within and between breeds are
advantageous for identifying regions of association through the use of methods such as
SNP array (BeadChip), GWAS, and fine mapping. (1,2,14,15-18).

The collie, the German Shepherd dog, and the Cavalier King Charles spaniel (Fig.
1) are examples of three breeds with genome variations leading to alternate phenotypic
traits such as snout length and shape, fur length, body size and ear position. The collie
originated from Scotland and Northern England, where it was selected for its sheep
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herding abilities (19). The standard collie has either long or short fur, a distinctive long
nose (dolichocephalic) and upright ears (15,19). The German Shepherd dog was
originally a herding dog (20), but it is now prized for its aptitude for learning new skills,
and protective nature (20). They have long fur, mid-length noses (mesocephalic) and tall
pointed ears (15,20). The Cavalier King Charles spaniel however, is a type of English toy
spaniel bred for companionship (21,22). These dogs have flat faces (brachycephalic),
medium length fur, folded ears and a smaller physical size (22). These traits are examples
of monogenic or polygenic genome variations.

Fig. 1. Diverse phenotypes of a collie, German Shepherd dog (GSD), and Cavalier King Charles spaniel
(CKCS) (from left to right). The collie has a long nose, long or short fur, and upright ears. GSD have mid
length noses, large pointed ears and long dark fur, whereas CKCS have short noses, floppy ears and are
physically smaller (15,19-22).
Permissions for the images: 1. collie – Dr. Leigh Anne Clark, 2. GSD – Anne Skob, and 3. CKCS – the
Rinz family.
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SNP array (BeadChip) and GWAS have been the successfully applied as the
standard approach to identify the regions of association for the above traits (23-25).
Where fine mapping was employed the region of association was narrowed and in some
cases the causative mutation identified. For example, snout length and shape is a
polygenic trait with candidate regions on chromosomes 1 and 5 (23). The combinatorial
effect and identity of causative gene(s) has yet to be determined (23). The genetic basis
for long and short fur length is determined by a single SNP in exon 1 of FGF5, which
was identified by a GWAS approach and fine mapping of candidate genes (24). Although
a single IGF1 allele acts as a major determinant of small dog body size (25), a number of
other loci contribute modifier genes, including GHR, HMGA2, SMAD2, and STC2, which
influence overall body size, indicating that control of body size is a polygenetic trait (26).
Ear position, erect versus floppy ears, has been studied using a GWAS, however the
causative mutation was not determined, rather a 100 kb region of strongest association on
chromosome 10 near MSRB3 was identified (23).

In addition, canines have more than 350 known hereditary diseases, many with
similar clinical signs to humans (16), making the dog a promising model for the study of
genetic diseases as different breeds are predisposed toward certain diseases (27-29). The
increased homogeneity within a breed allows for the identification of a candidate
association region. When several breeds suffer from the same disease, due to the reduced
homozygosity between breeds, the region of interest can be significantly narrowed with
the ultimate goal of identifying the causative mutation (7). For example, collies, Shetland
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sheepdogs, and Labrador retrievers tend to get dermatologic diseases (4). Certain large
breed dogs such as German shepherd dogs, Labrador retrievers, and Great Danes, have a
tendency to develop hip dysplasia (30).

Identification of the genetic causes of disease has also used the standard SNP
array, GWAS and fine mapping approach. However, the introduction of whole-genome
resequencing using massive parallel sequencing (a.k.a. NGS) has recently proven to be a
powerful method in identifying genomic variations that can then be associated with
known disease phenotypes (31-33). Using the Korean Jindo dog, 339 SNPs in 222 genes
were identified, of which the study confirmed 89 SNPs in genes previously associated
with human disease (32). In future studies, SNPs and other genomic variations will be
used to identify candidate mutations responsible for diseases with no known genetic basis
in dogs and humans.

Avian
Studies on phenotypic variations in the chicken (Gallus gallus) using the SNP
array and GWAS approach have been delayed due to the lack of a suitable SNP array and
comprehensive comparative genomic tools (34). Only a few quantitative traits and
morphological variants have been classically mapped to a single gene mutation (35). A
major deterrent to design of a useful SNP array, i.e. at least 100k informative genetic
markers, was the lack of sufficient suitable genetic markers to accommodate the diverse
range of chicken breeds (>240) (34). Two proprietary low and medium density SNP
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arrays (3,000 and 60,000 genetic markers) were recently developed based on 7 breeds
(36-39).

In this study, I examined the genetic basis for the rumplessness and ear-tuft
phenotypes in the Araucana chicken (3) using the Illumina 60 k SNP array. The interest
in these phenotypes rests in the fact that they are two of the three required breed standard
traits for chicken fanciers in the United States (3,40), the third trait being the pea comb
(41). Moreover, the lack of the tail vertebrae and associated soft tissue structures and the
craniofacial anomalies in the ear-tufted birds are potential models for human diseases.
Using the SNP array and GWAS analysis, I identified the region of association for each
phenotype. Both traits segregate independently in the population; therefore, we were able
to use individuals from the same population for each GWAS (3). Rumplessness was
associated with a 2.14 Mb region on chromosome 2; and the ear-tufts phenotype was
associated with a 0.58 Mb region on chromosome 15 (3) (Chapter IV).

Since this study, a large collection of SNPs that segregate within >243 chicken
populations, has been identified (34). In 2013, a high-density 600k SNP array was
developed in conjunction with Affymetrix and it is the first commercially available SNP
array for the chicken (34). Our study, among a handful of others, provided the proof of
principle for the SNP array and GWAS approach in identifying the genetic basis of
chicken traits and diseases (3,38,39,42,43).
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TECHNIQUES
In this section I briefly discuss the main techniques used throughout this study.
The first section covers genetic techniques: linkage disequilibrium mapping and genomewide association studies. In the second section two genomic techniques used include
microarray analysis and next-generation sequencing. Finally, I briefly discuss some of the
limitations of these approaches.

Genetic – linkage disequilibrium mapping
Linkage disequilibrium (LD) mapping utilizes the nonrandom association
between alleles at multiple loci, which may be on more than one chromosome, to find an
association with the phenotype of interest (44). LD is defined as the frequency of a
haplotype, i.e. co-inherited loci that do not exhibit the expected random recombination
(44). This method is used to identify marker-trait associations (45). Unlike, linkage
mapping, LD is measured in base pairs and is therefore a physical distance between
defined genetic markers. The more homozygous a species the longer the region of
homozygosity, up to 1 x 106 bp within dog breeds and about 1 x 104 bp between dog
breeds (6). This means that a relatively low number of genetic markers are needed for a
mapping study in dogs (46). Comparative genomics between the dog and humans (Homo
sapiens) show that humans have considerably less LD compared to the dog (46,47), i.e.
shorter regions of homozygosity. This means that humans are more heterogeneous than
the dog, exhibiting increased genetic diversity, and require larger numbers of genetic
markers for determining regions of association. In a further example, LD mapping and
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GWAS (discussed below) was used to identify recombination occurring in mitochondrial
DNA (mtDNA) in hominids (47). The combined LD mapping and GWAS data showed
reduced LD within mtDNA in both humans and chimpanzees (47).

Genetic – genome-wide association study
A genome-wide association study (GWAS) uses a set of genetic markers,
comparing two groups that vary by one phenotype, to identify an association between
genetic markers and the phenotype (48). This method is important because it does not
require previous knowledge of which genes or pathways the phenotype of interest is
related to (49). Advantages of the association method are 1) that association can detect
genes that have only a small effect on the phenotype, 2) that genetic markers closer to the
causative mutation can be identified, and 3) that unrelated individuals can be compared
(49), none of which is possible with the less informative classical linkage studies.

GWASs have been applied to humans, model organisms, and non-model
organisms (48). The predominant genetic marker being used for these associations is the
single nucleotide polymorphism (SNP) (49). Significant SNPs define a region of
association identifying a locus. Validation of SNPs is done using direct sequencing to
confirm that the SNP matches the association with the observed phenotype. Association
regions indicate the approximate region in the genome where the causative mutation of
the phenotype is located (50). GWAS in itself is unable to determine the nature of the
causative mutation. The causative mutation within the region of association needs to be

10

identified by fine mapping.

Genomic – polymorphism detection – microarrays
The use of microarrays to detect polymorphisms utilizes tens of thousands to
millions of oligonucleotide probes to hybridize target DNA to an array (51). The types of
probes may be sequence-specific oligonucleotide such as in the Affymetrix GeneChip®
assay (52). Two probes are designated as a set, and each set member will detect one allele
of a SNP (Allele A or Allele B) present in a DNA sequence (52). Another method, used
in Illumina Infinium BeadChip arrays, is to hybridize the fragments of sample DNA with
oligonucleotides attached to microbeads in order to detect SNPs (53).

The use of DNA microarray as a means for SNP detection was initially used to
identify the association of SNPs with cancer (53). SNP arrays generate profiles for
affected and unaffected populations (54). By conducting statistical comparisons, the
significant SNP(s) associated with the affected phenotype are identified (54). Since the
actual locations of the SNPs in the genome are known, candidate chromosomal regions of
interest can be analyzed to identify the genetic cause of the phenotype (54).

Genomic – polymorphism detection – next-generation sequencing
The introduction of massively parallel sequencing (a.k.a next-generation
sequencing (NGS)) has enabled identification of enormous numbers of SNPs and copy
number polymorphisms simultaneously (55). When compared to available reference
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sequences that structural variations within an individual genome can be identified (56).
Moreover, increasingly sophisticated algorithms have enabled the more accurate
generation of de novo reference sequences (55). These techniques have the power to alter
understanding of the mutational spectrum in model organisms and humans (55).

SNPs exist almost universally and have become the primary genetic marker for
genetic and genomic analyses (57). Based on the reduced costs, in addition to
improvements in next-generation sequencing (NGS) and the bioinformatics needed to
process the data, many projects to identify SNPs in model and non-model organisms have
been undertaken (57). There are 3 major NGS technologies, and, because of the dynamic
nature of their maximum capabilities, the method chosen for a specific type of research
project may vary (57). The 3 NGS technologies are: 454 or Roche sequencing, Illuminia
sequencing, and Applied Biosystems or SOLiD sequencing (57). In a single day, each
one of these platforms can generate upwards of 1 Gb of data (57).

In order to handle the amount and type of NGS data produced, many analysis
software packages are available, including, free and commercial, compatible on various
computer platforms, proprietary and flexible capabilities (57). Regardless of whichever
NGS platform and analysis software are used, the intended objective is usually to conduct
SNP discovery (57). SNP detection by NGS has been successful in humans, fruit flies,
grains, vegetables, and other species (57).
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The method by which SNPs are detected in NGS data depends on the presence or
absence of a reference genome (57). With a reference genome, a NGS read that aligns
with only a single mismatch to the reference genome will be called a SNP (57). Without a
reference genome, NGS reads produce a de novo genome assembly, and then aligned
reads are compared for a single mismatch (57). Both of these methods are theoretical
since the actual process requires additional information: read depth, quality scores, and
consensus base ratios (not discussed) (57).

Limitations of approaches
The above techniques have both strengths (as discussed above) and limitations.
Linkage mapping has shortcomings in that crossover events are not random. The
existence of one crossover can interfere with another one occurring in nearby proximity
(58,59). Multiple crossover events can cause underestimation of the recombination
frequency when such events occur between the two points being calculated (44). Another
issue that affects linkage between two loci is the existence of recombination hotspots in
eukaryotic chromosomes (60,61). Finally, in related individuals modes of inheritance
(epistasis, pleiotropy) can adversely affect the accuracy of linkage. As an example,
incomplete penetrance (where some individuals with the genotype do not display the
phenotype) can lead to a false negative (62).

Linkage disequilibrium mapping has weaknesses related to population
stratification. In population stratification, genetic markers may register a false positive
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(an association) or false negative (no association) in heterogeneous backgrounds (63,64).
Furthermore, as linkage disequilibrium measures the degree to which alleles at two loci
are associated, in related populations linkage disequilibrium analysis requires multiple
generations and large numbers of related individuals, to identify significant association
with the phenotype due to the homogeneity within the population (65).

When SNPs are used as the genetic marker, they do not exist in complete
independence (49). Although GWAS has been successful at identifying simple traits,
only a limited number of complex traits have been identified due to the complexity of
heritability (65). It is possible that rare variants, epistasis, epigenetics, and environmental
factors are being overlooked (65).

As for SNP arrays, two major limitations are the presence of nonspecific
hybridization and the extensive period required for hybridization (53). A further
limitation of microarrays is that there are batch effects that complicate the ability to
compare data, between experiments (66).

Although NGS is the most advanced technology, it too, has limitations. Variant
discovery is reliant on there being sufficient depth of coverage to accurately determine
variance (67). NGS platforms have biases in amplification from the PCR, resulting in
bias in amplification of certain transcripts and the introduction of errors within the
sequence (57).
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ABBREVIATIONS
Table 1. Abbreviations used throughout the introduction.
Name	
  
Abbreviation	
  
Cavalier	
  King	
  Charles	
  spaniel	
  
CKCS	
  
Dermatomyositis	
  
DM	
  
Genome-‐wide	
  Association	
  Study	
  
GWAS	
  
German	
  Shepherd	
  dog	
  
GSD	
  
Linkage	
  disequilibrium	
  
LD	
  
Megaesophagus	
  
ME	
  
Mitochondrial	
  DNA	
  
mtDNA	
  
Next-‐generation	
  sequencing	
  
NGS	
  
Pancreatic	
  acinar	
  atrophy	
  
PAA	
  
Single	
  nucleotide	
  polymorphism	
  
SNP	
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ABSTRACT
Episodic falling syndrome (EFS) is a canine paroxysmal hypertonicity disorder
found in Cavalier King Charles spaniels. Episodes are triggered by exercise, stress or
excitement and characterized by progressive hypertonicity throughout the thoracic and
pelvic limbs, resulting in a characteristic 'deer-stalking' position and/or collapse. We used
a genome-wide association strategy to map the EFS locus to a 3.48 Mb critical interval on
canine chromosome 7. By prioritizing candidate genes on the basis of biological
plausibility, we found that a 15.7 kb deletion in BCAN, encoding the brain-specific
extracellular matrix proteoglycan brevican, is associated with EFS. This represents a
compelling causal mutation for EFS, since brevican has an essential role in the formation
of perineuronal nets governing synapse stability and nerve conduction velocity. Mapping
of the deletion breakpoint enabled the development of Multiplex PCR and Multiplex
Ligation- dependent Probe Amplication (MLPA) genotyping tests that can accurately
distinguish normal, carrier and affected animals. Wider testing of a larger population of
CKCS dogs without a history of EFS from the USA revealed that carriers are extremely
common (12.9%). The development of molecular genetic tests for the EFS microdeletion
will allow the implementation of directed breeding programs aimed at minimizing the
number of animals with EFS and enable confirmatory diagnosis and pharmacotherapy of
affected dogs.

Keywords: Brevican, BCAN, Episodic falling syndrome, Cavalier King Charles, spaniels,
Microdeletion
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INTRODUCTION
Episodic falling syndrome (EFS) is a well-recognized paroxysmal disorder found in
Cavalier King Charles spaniels (CKCS). Episodes begin between fourteen weeks and
four years of age and are triggered by exercise, stress, apprehension or excitement (1).
Episodes are of variable frequency and severity but are characterized by progressive
hypertonicity involving thoracic and pelvic limbs (Fig. 1a) until the dogs are ultimately
immobilized in a characteristic 'deer-stalking' or 'praying' position (Fig. 1b). Stiffening of
all four limbs during exercise can cause falling (Fig. 1c), although there is no loss of
consciousness or cyanosis. Other clinical signs may include facial muscle stiffness,
stumbling, a 'bunny-hopping' gait, arching of the back or vocalization. Curiously,
between episodes, dogs appear to be completely normal neurologically. Spontaneous
activity was not observed in muscle electrodiagnostic testing, ruling out myotonia
congenita (2,3). Muscle biopsies are typically normal at the light microscopic level,
excluding many congenital myopathies.
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Fig. 1. Clinical signs of episodic falling syndrome and muscle pathology. A 5-month-old female Cavalier
King Charles spaniel presented with typical episodes of excitement or exercise-induced muscle stiffness (a,
hypertonicity) that would involve all four limbs and progress to an usual 'deer-stalking' or 'praying' posture
(b), eventually resulting in falling (c). While EFS muscle was normal histologically by light microscopy,
electron microscopy (d) revealed that the sarcoplasmic reticulum (sr) appeared dilated and contained finely
granular material compared to control muscle (e). Mitochondria (m) and myofibrils were normal in
appearance in both tissues. Scale bars = 0.31 µm.

However, EFS has been linked to ultrastructural defects in skeletal muscle
including dilatation and proliferation of the sarcoplasmic reticulum, mitochondrial
swelling and degeneration (2,3). EFS has also been compared (4) with startle
disease/hyperekplexia, typically characterized by noise- or touch-evoked neonatal
hypertonicity due to defects in inhibitory glycine receptor (GLRA1, GLRB; 5,6) or
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glycine transporter GlyT2 (SLC6A5) genes (7,8). However, a microdeletion in the GlyT2
gene in Irish Wolfhounds results in severe neonatal muscle stiffness and tremor in
response to handling (9), which is inconsistent with the observed clinical signs of EFS.
Comparisons with startle disease may have been made because affected dogs often
respond well to the benzodiazepine clonazepam (10), an effective anticonvulsant,
anxiolytic and muscle relaxant that is the most effective known treatment for human
hyperekplexia (11). However, the carbonic anhydrase inhibitor acetazolamide, used to
treat certain types of human episodic ataxia (12) and hyperkalemic periodic paralysis
(13), also appears to have therapeutic value in the treatment of EFS
(http://www.cavalierhealth.org/episodic_falling).

Since a ten-year breeder-led investigation into the inheritance of EFS suggested an
autosomal recessive mode of inheritance (http://cavalierepisodicfalling.com/), we used a
genome-wide association strategy (14) to map the EFS locus to a defined region of canine
chromosome 7. Candidate gene analysis enabled us to identify a microdeletion affecting
the brevican gene (BCAN), confirm the deletion breakpoint and develop rapid genotyping
tests for EFS.

MATERIALS AND METHODS
Light and electron microscopy:
For light microscopy, unfixed biopsies from the biceps femoris, vastus lateralis and
triceps brachii muscles were collected from five affected CKCS dogs under general
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anesthesia and frozen in isopentane pre-cooled in liquid nitrogen. Cryosections were cut
(8 µm) and the following histochemical stains and reactions performed: hematoxylin and
eosin, modified Gomori trichrome, periodic acid Schiff, phosphorylase, esterase, ATPase
reactions at pH of 9.8 and 4.3, nicotinamide adenine dinucleotide-tetrazolium reductase,
succinic dehydrogenase, acid phosphatase, alkaline phosphatase and oil red O. For
electron microscopy, glutaraldehyde-fixed muscle specimens were post-fixed in osmium
tetroxide, and dehydrated in serial alcohol solutions and propylene oxide prior to
embedding in araldite resin. Thick sections (1 µm) were stained with toludine blue for
light microscopy and ultrathin sections (60-90 µm) were stained with uranyl acetate and
lead citrate for electron microscopy.

Study cohort and DNA preparation:
Our study cohort comprised: EFS affected - 10 animals (6 from the USA, 2 from
New Zealand and 2 from the UK); Obligate EFS carriers - 8 animals (2 from the USA, 6
from New Zealand); Animals related to carriers or affected dogs - 21 animals (7 from the
USA, 14 from New Zealand); Controls - CKCS with no EFS history - 14 animals (all
from the USA). Genomic DNA was isolated from whole blood or buccal cells using the
Gentra Puregene Blood Kit (QIAGEN, Valencia, USA). Additional DNA samples from
155 CKCS with no clinical history of EFS and other pure bred-dogs were available from
unrelated studies and other sources (e.g.
Cornell DNA bank: http://www.vet.cornell.edu/research/dnabank/).
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Genome-wide association mapping:
Thirteen CKCS genomic DNA samples isolated from blood (five cases, one
obligate carrier and seven controls from the USA) were genotyped for 127,000 SNPs on
the Affymetrix Canine SNP Array version 2
(http://www.broadinstitute.org/mammals/dog/caninearrayfaq.html). The two main drivers
for sample selection were: i) lack of relatedness - i.e., that the animals used for casecontrol analysis should not share a common ancestor within at least three generations and
ii) the quality and quantity of genomic DNA available. Arrays were processed at the
Clemson University Genomics Institute (http://www.genome.clemson.edu/) using the
GeneChip human mapping 250K Sty assay kit (Affymetrix, Santa Clara, USA). The
GeneChip human mapping 500K assay protocol was followed, but with a hybridization
volume of 125 µl (14). Raw CEL files were genotyped using Affymetrix Power Tools
software. SNPs having >10% missing data and ≥60% heterozygosity were removed. Data
for 58,873 SNPs were formatted for PLINK (15) and case/control analyses with 100,000
permutations were performed for five cases and seven controls (the obligate carrier was
excluded from analysis).

PCR and DNA sequencing:
PCR primers were designed to amplify exons and flanking splice donor, acceptor
and branch-point sites, from gene structures derived in silico using the UCSC Genome
Browser. For exon-specific primers for BCAN and HAPLN2 exon amplification see Table
S1. PCR was performed using 50 ng genomic DNA as template and AccuPrime Pfx
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SuperMix supplemented with betaine for 40 cycles of 94°C for 1 min, 60°C for 1 min,
68°C for 1 min. PCR products were gel purified using a QiaQuick gel extraction kit
(QIAGEN, Crawley, UK) for TOPO cloning (pCR4Blunt-TOPO; Invitrogen, Renfrew,
UK). Sanger DNA sequencing was performed by DNA Sequencing & Services
(MRCPPU, College of Life Sciences, University of Dundee, Scotland) using Applied
Biosystems Big-Dye version 3.1 chemistry on an ABI 3730 automated capillary DNA
sequencer. DNA sequences were analyzed using Sequencher 4.10 (Gene Codes
Corporation, Ann Arbor, USA). For multiplex PCRs, the diagnostic primer set is: EFS1
5'-aaggtcttacacctgcaatgaatag-3', EFS2 5'-agcaaatgtaaagtcctgtgaccat-3' and EFS3 5'agttcacattgtgctctctctactg-3'.

Multiplex ligation-dependent probe amplification (MLPA) analysis:
Five MLPA probe sets were designed corresponding to the promoter region (PR)
and exons 1 (5' UTR), 2, 3 and 4 of the canine brevican gene (BCAN; NC_006589 on
chromosome 7; Table S2). Criteria for MLPA probe design were as previously described
(Schouten et al. 2002). A control probe pair was designed to recognize an unrelated gene
(CFTR: NC_006596 on chromosome 14). Probes generated amplification products
ranging in size from 88 to 115 bp and had annealing temperatures higher than 70°C as
recommended in RAW Probe software (MRC-Holland, Amsterdam, The Netherlands)
using standard MLPA conditions (Schouten et al. 2002). PCR products were analyzed on
an ABI 3130XL capillary electrophoresis apparatus (Applied Biosystems, Lennik,
Belgium). Normalization of BCAN- specific probe signals was performed by dividing the
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values obtained by the combined signal of the control probes.

RESULTS
Light and electron microscopy:
Unfixed cryosections of muscle biopsies were histologically normal at the light
microscopic level with no abnormalities detected following any of the histochemical
stains and enzyme reactions employed. Contrary to previous reports (2,3) electron
microscopy revealed normal myofibrillar and mitochondrial morphology, although
swelling of the sarcoplasmic reticulum was confirmed (Fig. 1d,e).

Genome-wide association mapping and candidate gene resequencing:
A total of 17 single nucleotide polymorphisms (SNPs) were associated with EFS
(Praw values ≤ 0.0001) (Table S3). The most significant result was for SNP 43389066
(Praw = 5.10×10-7, Pgenome = 2.68×10-3) (Fig. 2a). All significant SNPs were located
within a 7.2 Mb region on canine chromosome 7. A critical interval of 3.48 Mb (from
7.42838021 to 7.46320904) was delimited by recombinant chromosomes identified in
one EFS dog and an obligate carrier (Fig. 2b). In order to identify the mutation associated
with EFS, we prioritized several genes for resequencing based on biological plausibility.
These encoded ligand-gated or voltage-gated ion channels (CHRNB2, HCN3, KCNN3),
mitochondrial (MRPL24, MTSO1, MTX1, SLC25A44), muscle (MEF2D, TPM3) or brainexpressed proteins (ARHGEF11, BCAN, GBA, HAPLN2, NES, RIT1, SYT11, UBQLN4).
Curiously, amplification of BCAN exons 1, 2 and 3 consistently failed with multiple
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primer sets when using genomic DNA from affected animals, while DNAs from carriers
and unaffected dogs amplified reliably (Fig. 3a). Because no preferential amplification
was observed for the adjacent gene, HAPLN2 - encoding hyaluronan and proteoglycan
link protein 2/Bral1 (16-18) - we suspected that a microdeletion affecting BCAN
regulatory sequences and exons 1-3 was associated with EFS.
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Fig. 2. Mapping the episodic falling syndrome locus. (a) –log10 of Praw values (Y axis) for genome-wide
association using five EFS and seven control dogs are plotted for each chromosome (X axis). A single
major signal was detected on chromosome 7. (b) A 3.48 Mb critical interval encompassing SNP 43389066
is defined by recombination events in an affected CKCS and an obligate carrier.
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Deletion breakpoint identification and development of diagnostic tests:
Further primer walking experiments enabled us to clone and sequence a DNA
fragment containing the deletion breakpoint and develop a multiplex PCR assay that
distinguishes between affected, carrier and normal dogs (Fig. 3b). Sequence analysis of
the breakpoint amplicon revealed a 15.7 kb microdeletion starting 1.56 kb downstream of
HAPLN2, encompassing BCAN promoter elements and exons 1 (5' untranslated), 2 and 3,
finishing 85 bp downstream of BCAN exon 3 (Fig. 3c). The microdeletion amplicon also
contained a 6 bp inserted sequence (GGCCTT; Fig. 3d) typical of deletions resulting
from non-homologous end joining (NHEJ) or microhomology-mediated end joining
(MMEJ). Several regions of microhomology (1-7 bp) were identified in a 30 bp region
encompassing the breakpoints (Fig. 3e). Interestingly, 5 of 6 bp of the reverse
complemented inserted sequence aligns to the largest region of microhomology. We also
noted an abundance of short interspersed element (SINE) insertions at the 5' end of the
deleted sequence, which could cause the formation of secondary structures that facilitate
chromosomal rearrangement (19). We also detected the presence of the BCAN
microdeletion (Fig. 4) using MLPA (20) and canine-specific probe sequences (Table S3).
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Fig. 3. (a) PCR panels for BCAN exons 1–4 showing that amplicons for the first three exons of the
brevican gene can be generated from genomic DNA from normal (+/+) or obligate carrier (+/-) samples,
but cannot be amplified from an equivalent EFS sample (-/-). By contrast, BCAN exon 4 can be amplified
from all genotypes. (b) Multiplex PCRs with primers flanking the 15.7 kb BCAN microdeletion allowed
simultaneous detection of the wild-type BCAN allele (primers EFS1 + 2, 393 bp) in normal (+/+) or EFS
carrier (+/-) animals, while the EFS allele (primers EFS1 + 3, 273 bp) is detected in both EFS carrier and
affected (-/-) dogs. Note that the two carriers shown have both wild-type and EFS amplicons, as expected
for a heterozygous genotype. (c) Schematic diagram showing the genomic organization of the HAPLN2
and BCAN, the position of the deletion (grey shading) and EFS1-3 primers. (d) Sequence spanning the
BCAN deletion breakpoint, showing an additional non-homologous inserted sequence indicated by arrows.
(e) Alignment of the DNA sequence immediately flanking the deletion breakpoint indicating local
microhomology.
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Fig. 4. Position of the EFS microdeletion. Genomic DNA from canine chromosome 7 highlighting exons
1–4 of BCAN and the position of the 15.7 kb EFS microdeletion (grey shading).

This quantitative analysis also confirmed that EFS is associated with a loss of
BCAN promoter/regulatory elements and exons 1-3 in heterozygous carriers and
homozygous affected animals (Fig. 5).
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Fig. 5. Confirmation of the BCAN microdeletion using Multiplex Ligation-dependent Probe Amplification.
(a) MLPA analysis revealed robust detection of a control probe (CFTRa) and probes for the BCAN
promoter/regulatory region (PR) and exons 1–4. However, signals for probes PR and exons 1–3 were
reduced by 46–55% in heterozygous (+/-) animals and abolished in homozygous animals (-/-), consistent
with a loss of probe binding sites in genomic DNA.

Rapid genotyping using multiplex genotyping in different dog populations:
To assess the prevalence of the EFS microdeletion, we used our multiplex PCR
assay to test several CKCS populations and other dog breeds (Table 1). All affected dogs
in our study cohort - from the UK (n = 2), USA (n = 6) and New Zealand (n = 2), were
homozygous for the BCAN microdeletion. In addition, all obligate carriers were
heterozygous (n = 2 from the USA and n = 6 from New Zealand). In animals related to
affected dogs, we found 9 normal animals and 10 carriers. Interestingly, in this group,
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Genotypes revealed by multiplex PCRs were determined as described in Materials and methods. Dogs were
evaluated on the basis of available clinical data and placed into one of the phenotype categories above.
Note that all clinically affected animals were homozygous for the BCAN deletion, whilst obligate carriers
were heterozygous. As well as wild-type animals and carriers of the BCAN deletion, two dogs homozygous
for the BCAN deletion, which were not reported to have classical clinical signs of EFS, were detected in a
cohort of animals related to known EFS dogs. Carriers were also detected in CKCS with no history of EFS,
but not in control DNA samples from 54 other dog breeds including: Airedale terrier, Akita Basenji,
American Staffordshire Terrier, American Cocker Spaniel, American Eskimo Dog, Australian Shepherd,
Akita Basenji, Bernese Mountain Dog, Bluetick Coonhound, Border collie, Boston Terrier, Boxer, Boykin
Spaniel, Briard, Bull Mastiff, Bulldog, Cairn Terrier, Catahoula Leopard Dog, Chihuahua, collie,
Dachshund, Dalmatian, English Setter, English Springer Spaniel, Flat Coated Retriever, German Shepherd,
Giant Schnauzer, Golden Retriever, Great Dane, Havanese, Siberian Husky, Irish Setter, Italian Greyhound,
Labrador Retriever, Miniature Pinscher, Miniature Poodle, Miniature Schnauzer, New Guinea Singing
Dog, Norwegian Elkhound, Petit Basset Griffon Vendeen, Pomeranian, Portuguese Podengo Pequeno, Pug,
Pyrenean Shepherd, Schipperke, Shetland Sheepdog, Swedish Vallhund, Tibetan Terrier, Toy Fox Terrier,
Weimaraner, Welsh Terrier, West Highland White Terrier, Wire Fox Terrier and Yorkshire Terrier. Where
possible, two unrelated dogs were tested for each breed.

two dogs without a classical clinical history of EFS were homozygous for the
microdeletion. Lastly, in dogs with no known clinical history of EFS sourced from the
USA, the carrier frequency was 12.9% (20/155) suggesting that the EFS microdeletion is
present at a high frequency in this population. Notably, the mutation was not detected in
multiplex PCRs conducted on control DNA samples from 54 other breeds of dog (Table
1).
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DISCUSSION
The genomic architecture of pure-bred dog lines is ideal for the identification of
loci responsible for autosomal recessive traits using genome-wide association mapping
(14,21). In this study, we demonstrate that this technique can be used successfully on
minimal samples sets, since we located the EFS locus using DNA samples from only five
affected and seven breed-matched control dogs. Since a homozygous haplotype spanning
6.35 Mb was identified in affected animals, it is questionable whether further SNP typing
would have generated additional useful data. In fact, a single recombination event in an
obligate carrier allowed us to narrow the critical interval to 3.48 Mb. This region
contained >100 genes, including ligand-gated ion channels, K+ channels, transporters,
mitochondrial proteins and several genes known to be involved in neurological disorders
in humans. For example, mutations in CHRNB2 are associated with nocturnal frontal lobe
epilepsy (22) and TPM3 mutations are associated with nemaline myopathy (23).
However, many of these genes were rapidly eliminated as candidates due to either: i)
poor correlation of EFS clinical signs with the equivalent human disorders or ii)
systematic resequencing of the genes. Consistent with the unique clinical signs observed
in affected dogs, we discovered that a homozygous microdeletion affecting BCAN is
associated with EFS in CKCS dogs, confirming that this disorder is inherited in an
autosomal recessive manner. This mutation was not detected in control DNA samples
from 54 other dog breeds, confirming the unique nature of this genomic rearrangement.

Brevican belongs to the lectican family of aggregating extracellular matrix (ECM)
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proteoglycans, which comprises aggrecan, brevican, neurocan and versican. Although
mutations in the aggrecan and versican genes (ACAN: 15q26.1 and VCAN: 5q14.2-14.3)
have been linked to different connective tissue disorders (24-26; Fig. 6), no mutations in
the brevican or neurocan genes (BCAN: 1q23.1 and NCAN: 19p13.11) have been
identified to date. Brevican and neurocan are highly expressed in the central nervous
system, where they are found in specialized extracellular matrix structures called
perineuronal nets that play a role in cell adhesion, migration, axon guidance and neuronal
plasticity (27).
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Fig. 6. Modular organization of the superfamily of hyaluronan-binding proteins and associated disorders.
Mutations in ACAN, encoding aggrecan—a major component of cartilage, have been implicated in
spondyloepiphyseal dysplasia type Kimberley (24) and familial osteochondritis dissecans (25). Mutations
in VCAN, encoding versican, are associated with Wagner syndrome and erosive vitreoretinopathy,
disorders affecting the connective tissue of the eye (26). Modified from (28).

Brevican, versican, HAPLN2/BRAL1, tenascin-R and phosphacan are also present at the
nodes of Ranvier on large diameter myelinated axons (18,29) where cations are
accumulated and depleted in the local extracellular nodal region during action potential
propagation. The ECM complex at nodes of Ranvier is thought to play a pivotal role in
maintaining a local microenvironment, acting as a diffusion barrier for K+ and Na+
around the perinodal extracellular space (17,18). Thus, disruption of ECM complexes
governing synapse stability and nerve conduction velocity are likely to underlie the EFS
phenotype. Certainly, since EFS appears to result from a central nervous system rather
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than a muscle defect, the associated sarcoplasmic reticulum pathology is likely to be a
secondary manifestation of muscle overstimulation (30). Interestingly, BCAN knockout
mice were not reported (27) to have a phenotype similar to EFS - although an increased
grip-strength was noted, which could be indicative of increased muscle tone. However, it
is questionable whether current mouse phenotyping tests will reveal neurological
disorders evoked by strenuous exercise, stress, apprehension or excitement, since these
conditions are generally avoided in mouse care. It is also noteworthy that EFS clearly
shows variable age of onset and penetrance. For instance, we identified two dogs that
were homozygous for the BCAN microdeletion that had not shown classical clinical signs
of EFS in the presence of their owners. Interestingly, similar findings were reported for
the dynamin (DNM1) mutation (p.R256L) underlying exercise-induced collapse in
Labrador retrievers (31). It is plausible that these dogs have not been exposed to
sufficient exercise or excitement to trigger an episode, or that genetic or environmental
modifying factors (e.g. diet) affect the onset of these disorders. However, it is notable that
one of the two asymptomatic dogs in our study was described as 'exercise resistant' by
their owner, suggesting that adaptive behavior may occur in dogs that are homozygous
for the BCAN microdeletion. It must also be emphasized that such non-classical cases are
rare - we did not find a single dog that was homozygous for the BCAN microdeletion in
155 CKCS with no clinical history of EFS (Table 1).

In summary, we have shown that an inactivating microdeletion affecting BCAN is
associated with EFS in CKCS dogs. Identification of the deletion breakpoint has allowed
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the development of diagnostic tests that have revealed a high prevalence of carriers
(12.9%) in clinically unaffected dogs from the USA. These genetic tests (available via
Laboklin: http://www.laboklin.co.uk/) will enable future identification of heterozygous
animals (which have no discernable phenotypic difference to wild-type animals) allowing
directed breeding programs to be implemented, and confirmatory diagnosis and
appropriate pharmacotherapy of affected animals. Since this also represents the first
report of a genetic disorder involving a neuronal-specific ECM proteoglycan, we suggest
that BCAN and NCAN should be considered as candidate genes for genetic analysis in
unresolved cases of human disorders with similar clinical presentations to EFS, such as
paroxysmal exercise-induced dyskinesias (32) or episodic ataxias (12).
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ABSTRACT
The German shepherd dog (GSD) is an extremely popular working and companion breed
for which over 50 hereditary diseases are documented. Herein, we generated SNP profiles
for 197 GSDs using the Affymetrix v2 canine SNP array and employed a genome-wide
association strategy to find loci associated with four diseases: pituitary dwarfism,
degenerative myelopathy (DM), congenital megaesophagus (ME), and pancreatic acinar
atrophy (PAA). A strongly associated locus on chromosome 9 was detected for pituitary
dwarfism, and is proximal to a plausible candidate gene, LHX3. Results for DM confirm
a major locus encompassing SOD1, in which an associated point mutation was previously
identified, but do not suggest significant modifier loci. Several SNPs on chromosome 12
were found to be associated with ME and a 4.7 Mb haplotype block was identified.
Analysis of additional affected dogs for a SNP within the haplotype provides further
support for the association. Results for PAA indicate more complex genetic
underpinnings. Loci on 23 chromosomes reached genome-wide significance. No major
locus was detected and only two weakly associated haplotype blocks, on chromosomes 7
and 12, could be detected. These data suggest that PAA may be governed by multiple loci
with small effects, or may be a heterogeneous disorder.
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INTRODUCTION
Shepherds and hounds were the earliest dog breeds developed to serve in
specialized roles (1). The German shepherd dog (GSD), for which the standard was
originally developed in 1899, was bred for utility and intelligence and to be a multipurpose servant of humans (1). Aptitude, temperament, structural efficiency and other
natural skills were selected for over aesthetic traits. Today, the GSD is among the most
common breeds trained in specialized jobs for the military, law enforcement, and
service/assistance programs (2). The GSD is also an extremely popular companion,
ranking second in breed registration statistics reported by the American Kennel Club in
2010. Unfortunately, despite a large population size and outbreeding practices, over 50
hereditary diseases plague the GSD (3).

Pituitary dwarfism is a rare disease of GSDs characterized by an abnormally small
body structure due to a deficiency in pituitary growth hormone. Dogs appear to be normal
at birth, but signs of slowed growth are usually evident by 2-3 months of age. There are
no treatments available for dogs and their lifespan may be significantly shortened.
Pituitary dwarfism in the GSD is inherited in an autosomal recessive fashion (4).
Combined pituitary hormone deficiency (CPHD) in the human is a type of growth
hormone deficiency that results from a decrease in several hormones necessary for
pituitary development. Mutations that cause congenital CPHD in the human have been
identified in several transcription factors important for pituitary development, such as
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PIT1, PROP1, LHX3, LHX4, HESX1 (5). Sequencing of PIT1 (6), PROP (7), LHX4 (8),
and LIFR (9), did not reveal any causative variants.

Degenerative myelopathy (DM) is a late-onset neurodegenerative disease
characterized by ataxia and weakness in the hind limbs. Symptoms of DM worsen over
time, either steadily or in phases, and eventually result in complete paraplegia. In some
cases, DM may progress up the spinal cord and cause forelimb weakness and respiration
difficulties (10). Age of onset is generally between 5 and 14 years, with a mean onset of 9
years (11). The clinical signs observed in DM are general indicators of spinal cord
disorders; definitive diagnosis for DM can only be made by histopathological
examination of spinal cord tissue postmortem (12). Most owners of affected dogs elect
euthanasia within several months of the onset of clinical signs (13). DM is most prevalent
in the GSD (12). A recessive missense mutation in SOD1 is associated with DM in
several breeds, including GSDs (14). DM has been proposed to be a large-animal model
for amyotrophic lateral sclerosis (ALS). Approximately 20% of hereditary ALS cases are
attributed to mutation of SOD1 (15).

Congenital idiopathic megaesophagus (ME) is characterized by dilation and
hypomotility of the esophagus. The result of these anomalies is regurgitation several
minutes to hours after eating. Regurgitation episodes may occur as often as several times
a day or as infrequently as once every few days. Symptoms for congenital ME typically
begin around five weeks of age after weaning onto solid food. Affected puppies are
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malnourished, show a general failure to thrive, and are at risk for aspiration pneumonia.
Diagnosis of ME is achieved by standard X-rays and/or fluoroscopy (barium swallow)
(16). ME is typically treated by feeding a high calorie, liquid diet from a raised dish (16).
Mortality is high in affected neonates. Many survivors require lifelong management of
the disorder, but other cases resolve by four to six months of age (17). ME is prevalent in
the GSD, Great Dane, miniature schnauzer, Rhodesian ridgeback, dachshund, and wire
fox terrier breeds, and is also reported to occur at lower frequencies in many other breeds
(18). Several loci are thought to be responsible for ME in the dog (17), but the mode of
inheritance in the GSD has not been investigated.

Pancreatic acinar atrophy (PAA) is an autoimmune disease characterized by the
selective atrophy of the acinar cells of the pancreas, which produce and secrete digestive
enzymes (19). PAA is the most common cause of exocrine pancreatic insufficiency (EPI)
in the dog (20) and is diagnosed through histopatholgic examination (21). EPI is
diagnosed through measurement of serum canine trypsin-like immunoreactivity (cTLI),
with concentrations < 2.5 µg/L diagnostic for EPI (22). Ninety-six percent of affected
dogs present with clinical signs of EPI, including weight loss, increased appetite, and soft
stools, by five years of age (20,23). Affected dogs can be treated with pancreatic enzyme
supplements, although dogs with EPI are often euthanized because of the expense of
treatment or poor treatment response (24,25). PAA is a disorder that is widespread in the
GSD population, but also affects many other breeds including collies (26,27). Recent
inheritance studies in the GSD show that EPI is likely a polygenic disorder (28).
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The development of high-throughput genotyping technologies has facilitated the
discovery of genes responsible for simple and complex phenotypes of the dog (29,30).
The population structure of the dog is particularly well-suited for association mapping
techniques because genetic bottlenecks during breed formation created large blocks of
linkage disequilibrium within breeds (29). Reported here is the use of a large cohort of
GSDs to investigate the afore- mentioned four diseases that segregate in the population.
Genetic profiles for 197 GSDs were generated using the Affymetrix v2 canine SNP array.
Using a single data set, we carried out genome-wide association studies (GWAS) to
identify risk loci for four diseases of the GSD.

MATERIALS AND METHODS
Sample Collection
Samples were recruited from purebred GSDs that had been diagnosed with EPI,
DM, or ME through standard veterinary diagnostic procedures. DM cases were diagnosed
by veterinary neurologists. Dogs were considered to have congenital idiopathic ME if
they did not have conditions that cause secondary ME, such as persistent right aortic arch
and myasthenia gravis. Purebred GSDs collected as controls were at least six years of age
and, to the owners’ knowledge, had no immediate family members affected with EPI,
DM, or ME. Cases and controls were selected to have as few close relatives (within three
generations) in the study cohort as possible. Samples were acquired from the United
States, Canada, Germany, and the Netherlands. Owners were asked to report all known
hereditary conditions, as well as coat color phenotypes.

56

Whole blood or buccal swabs were submitted by dog owners. Blood samples were
collected by owners’ private veterinarians. All samples were collected in accordance with
protocols approved by the Clinical Research Review Committee (CRRC No. 07-04) at
Texas A&M University and the Clemson University Institutional Review Board
(IBC2008-17). Genomic DNA was isolated using the Gentra Puregene Blood Kit
(Qiagen, Valencia, CA, USA). Serum samples were collected from all EPI cases and
controls and submitted to the Gastrointestinal Laboratory at Texas A&M University for
measurement of cTLI to confirm clinical status. Concentrations ≤2.5 µg/L were
considered diagnostic for EPI. Control dogs had concentrations ≥5.7 µg/l. All EPI cases
were assumed to result from PAA, but tissue samples were not available to differentiate
EPI due to PAA or another cause of EPI.

GWAS
SNP genotypes were generated using the Affymetrix Canine SNP Array version 2
(http://www.broadinstitute.org/mammals/dog/caninearrayfaq.html). Arrays were
processed at the NHGRI or Clemson University Genomics Institute
(http://www.genome.clemson.edu/) using the GeneChip human mapping 250K Sty assay
kit (Affymetrix, Santa Clara, USA). The GeneChip human mapping 500K assay protocol
was followed, but with a hybridization volume of 125 µl (29). Raw CEL files were
genotyped using Affymetrix Power Tools software. SNPs having >10% missing data and
≥60% heterozygosity were removed from the data set. Case/control analyses were
performed on the 48,415 SNPs from the ‘‘platinum’’ set using PLINK (31), with Praw <
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0.0001 considered significant. To determine Pgenome values (EMP2), permutation
testing (100,000) was performed for PAA, DM, and ME analyses using PLINK. A less
conservative correction, Benjamini–Hochberg, was also performed (32). Analysis of
population stratification in 197 GSDs was conducted using identity-by-state clustering
and multidimensional scaling in PLINK. The data, in a reduced representation, were
plotted in two dimensions: principal components 1 and 2.

Genotyping of SNP 12.60274687
Primers flanking the SNP 12.60274687 were designed: forward: 5’ TGAGCACACAGAGGTGAGACAT-3’ and reverse: 5’ CAGTGGGAGGGTTTAGGAAGAGAT-3’ . SNP 12.60274687 was amplified for 35
additional ME dogs using Thermo ReddyMix (Thermo Fisher Scientific, Waltham, MA,
USA) following the recommended proto- col. Thermal cycling conditions were as
follows: 95°C for 15 min; 14 cycles of 95°C for 30 s, 62°C for 1 min (decreasing 0.5°C
each cycle), 72°C for 1 min; 20 cycles of 95°C for 30 s, 55°C for 1 min, 72°C for 1 min;
72°C for 10 min. PCR amplicons were analyzed by electrophoresis on agarose gels.
Products were purified by adding 0.5 unit exonuclease I (New England Biolabs, Ipswich,
MA, USA) and 0.25 unit of shrimp alkaline phosphatase (Promega, Madison, WI, USA)
and incubating for 30 min at 37°C followed by 20 min at 80°C. Nucleotide sequencing
was accomplished using the Big Dye Terminator version 3.1 Cycle Sequencing kit
(Applied Biosystems, Carlsbad, CA, USA). Products were purified using Spin-50 mini
columns with water (BioMax, Inc., Arnold, MD, USA) and resolved on an ABI Prism
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3730 Genetic Analyzer (Applied Bio- systems). Sequences were analyzed to determine
SNP genotypes. Odds ratios (OR), critical intervals, and x2 tests were calculated to assess
the differences in genotype frequencies between the two populations using 2 x 2
contingency tables.

RESULTS
Validation
In total, 197 GSD samples were acquired from the United States, Canada,
Germany, and the Netherlands. Two GSDs were affected with EPI and DM. One GSD
was affected with EPI and ME. Principal component analysis with PLINK showed no
evidence for population stratification within our GSD cohort (n = 197) using all
‘‘platinum’’ SNPs (Fig. 1). To validate both our genotype data and statistical approach,
we first mapped a positive control trait. Ten dogs in the study cohort had white coats, a
recessive trait caused by the e allele of MC1R in the GSD (33). GWAS using 197 GSDs
(10 cases, 187 controls) reveals a strongly associated region encompassing MC1R on
chromosome 5 (Fig. 2a). SNP 5.66900853, the most significant result (Praw = 3.61 9 1022), is located approximately 208 kb adjacent to the E locus. The lack of subpopulations,
combined with our ability to accurately map a known locus, indicates the utility of this
data set.
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Fig.1 Principal component analysis of the GSD cohort shows all 197 dogs clustering together. The x axis is
principal component 1 and the y axis is principal component 2. Two individuals that appear apart from the
main grouping have the largest proportion of missing data (22.7 and 22.4% overall, compared to the
average missing data rate of 12.6%)
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Fig. 2 Manhattan plots showing the results for GWAS using 48,415 SNPs. The genome-wide P values (log10 P) for each SNP are plotted against position on each chromosome. a Ten white GSDs versus 187
nonwhite GSDs show a strong association on chromosome 5. b Four pituitary dwarf GSDs versus 193
normal-sized GSDs show a strong association on chromosome 9.
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Pituitary dwarfism
Four dogs in our control population have pituitary dwarfism. GWAS using these
four cases and 193 normal-sized controls, showed a major region of association on
chromosome 9 (Fig. 2b). Within this region, all four pituitary dwarfs were homozygous
for a haplotype extending from SNP 9.52031784 to SNP 9.54102643. The haplotype was
never observed in the homozygous state among the control dogs, and was heterozygous
in 15 control dogs. The most significant result, SNP 9.53350831 (Praw = 2.04 × 10-10), is
located approximately 764 kb from a candidate gene, LHX3.

Degenerative myelopathy
GWAS with 100K permutations for DM were carried out using all cases collected
(n = 15) and control dogs that were at least eight years of age and had exhibited no
clinical signs of DM (n = 69). The two most significant results were for SNPs
31.28909487 (Praw = 8.51 × 10-06, Pgenome = 0.1461) and 31.30528862 (Praw = 5.59 × 10-05,
Pgenome = 0.5771) (Fig. 3a). These SNPs on chromosome 31 are located 650 kb upstream
and 965 kb downstream of SOD1, respectively. Evaluation of genotypes in this region
showed that only four of the 15 cases were homozygous at both loci. Five cases were
homozygous for the associated allele of SNP 31.30528862, while nine cases were
homozygous for the associated allele of SNP 31.28909487. In the control population, six
of 69 GSDs were also homozygous for the same allele of SNP 31.28909487. A third
significant result was detected on chromosome 10 for SNP 10.64801770 (Praw = 6.06 ×
10-05, Pgenome = 0.6066).
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Fig. 3 GWAS using 48,415 SNPs with 100,000 permutations. The genome-wide adjusted P values (–log10
P) for each SNP are plotted by chromosome. a Fifteen GSDs with DM versus 69 healthy control GSDs. b
Nineteen GSDs with ME versus 177 healthy control GSDs. c One-hundred GSDs with PAA versus 79
healthy control GSDs.
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Megaesophagus
GWAS with 100,000 permutations were carried out using 19 cases and 177
control dogs. Significant results were obtained for 14 SNPs on eight different
chromosomes (Fig. 3b). Of the 14 significant results, three were located within an eight
Mb region on chromosome 12. Five other SNPs within this region are approaching
significance. The most significant of these is SNP 12.60274687 (Praw = 1.49 × 10-5,
Pgenome = 0.3099). Analysis of genotypes for this SNP revealed that all affected dogs share
a common allele (frequency = 0.83) that was less prevalent among control dogs
(frequency = 0.46). To further investigate this finding, 35 additional ME GSDs were
collected and genotyped for the SNP. Genotype frequencies and odds ratios for SNP
12.60274687 are shown in Table 1. Further analysis of genotypes on chromosome 12
revealed a haplotype block extending 4.7 Mb that is present in all affected dogs.

Pancreatic acinar atrophy
GWAS with 100,000 permutations were carried out using 100 cases and 79
control dogs (Fig. 3c). Significant Praw values were obtained for 50 SNPs on 23
chromosomes (Supplementary Table 1). Chromosome 12 harbors seven significant SNPs,

64

three of which are found in a cluster: 12.3781476, 12.3845215, and 12.4698937.
Chromosome 7 harbors six significant SNPs, four are found in a cluster: 7.11222056,
7.12305239, 7.12310223, 7.12424701. On ten chromosomes, only one SNP each is
strongly linked with PAA. On the remaining 11 chromosomes, no two strongly associated
SNPs were located within 5 Mb of each other and no common haplotypes are detected.
Six SNPs had minor allele frequencies (MAF) < 15%.

DISCUSSION
Pituitary dwarfism
Autosomal recessive traits of the dog can be mapped using remarkably small
numbers of cases (34,35). In this study, a mere four cases were sufficient to detect strong
linkage to chromosome 9 and define a two Mb pituitary dwarfism haplotype. While the
critical interval harbors more than 40 loci, one gene is an intriguing candidate: LHX3, a
LIM homeodomain transcription factor vital for pituitary and motor neuron development
(36). Genetic variations within LHX3 cause CPHD in humans (37,38). Although some
mutations in LHX3 are also associated with a rigid cervical spine, mental retardation, and
deafness (37,39,40), the GSD pituitary dwarfs do not have clinical signs that indicate
nervous system involvement (41). In mice, complete loss of LHX3 is lethal (42), but
mutations within the gene cause a dwarfism phenotype (43,44).

Recently, Voorbij et al. announced the availability of a genetic test for pituitary
dwarfism in the GSD (45), but information regarding the gene or mutation has not been
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published to date. Dwarfism in the GSD is reportedly rare and utilization of the genetic
test could facilitate rapid elimination of the phenotype. Our data are surprising because
the frequency of the two Mb haplotype in our control dogs is four percent, suggesting a
roughly eight percent carrier frequency in the general population. Moreover, this estimate
is likely low because only dogs having the complete two Mb haplotype were considered
to be carriers, thereby excluding dogs with partial overlapping haplotypes that may have
the causative mutation.

Degenerative Myelopathy
DM is a devastating disorder of GDSs that has been difficult to eradicate from the
breed, in part because of a late age of onset and poor diagnostic tools. We identified two
SNPs on chromosome 31 that were strongly associated with the DM phenotype. The
SNPs flank SOD1, the gene in which Awano et al. (14) identified an E40K missense
mutation in DM-affected dogs from several breeds. The authors propose that the mutation
causes DM in an autosomal recessive fashion (14). In our study, only nine of 15 cases
were homozygous for the more tightly linked SNP, suggesting that either our relaxed
diagnostic criteria (dogs were not diagnosed postmortem) may have led to the inclusion
of dogs that were misdiagnosed, or that heterozygosity for the mutation can produce an
affected phenotype. Recombination between the SNP, located 652 kb from the SOD1
exon two mutation, may also be a factor (five cases were heterozygous). Only six of 69
dogs in our control population were homozygous for the SNP, corresponding to nine
percent affected controls. Similarly, Awano et al. (14) reported that six percent of GSD

66

breed controls were homozygous for the SOD1 mutation. The high frequency of
clinically normal, aged controls that are homozygous for the mutation suggests the
involvement of modifier loci and/or environmental factors. In our analysis, a second
significant locus is detected on chromosome 10 and is supported by six proximal SNPs
with P values approaching significance (< 0.00086). Awano et al. (14) detected weaker
signals of association on chromosomes 6, 18, 20, and 35. Our data do not support regions
of association on chromosomes 18 and 35, but do show modest signals on chromosomes
6 and 20.

Megaesophagus
The mode of inheritance of ME has not been previously investigated in the GSD,
but it has been suggested that the frequent occurrence of affected puppies born to
clinically normal parents serves as evidence for a recessive mutation. In this work we
successfully mapped two simple autosomal recessive traits with ten and four cases and a
complex recessive trait with 15 cases. GWAS using 19 dogs with ME, however, did not
yield a single, strong region of association. Rather, minor associations were detected on
eight different chromosomes. It is, therefore, unlikely that ME is inherited in an
autosomal recessive fashion in the GSD. Similarly, evaluation of inheritance patterns of
ME in the Miniature Schnauzer did not suggest a simple recessive mode of inheritance
(17).
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A locus on chromosome 12 is the only one to reach genome-wide significance
and have supporting proximal SNPs (8 SNPs having Praw values <0.00014). To verify an
association, 35 additional ME GSDs were collected and genotyped for the most strongly
associated SNP in this region. In total, 53 of 54 ME cases were heterozygous or
homozygous for the associated allele, which occurs at a significantly lower frequency in
the control population. These data are consistent with an autosomal dominant mode of
inheritance, with incomplete penetrance and/or modifying loci. On the other hand, it is
also conceivable that the allele is fully penetrant but that the control population includes
dogs with undetected ME. ME varies in severity and can resolve completely after a few
months, making detection of mild cases difficult.

The dilation and lack of muscle contraction in the esophagus is thought to be a
neurological defect rather than a muscular defect (16). The associated haplotype on
chromosome 12 harbors approximately 12 genes, several of which are expressed in the
nervous system. Additional genome-wide SNP analyses in ME GSDs are necessary to
confirm this association.

Pancreatic acinar atrophy
Fifty SNPs, representing 45 loci, exceeded genome-wide significance thresholds
for association with PAA. A majority of significant SNPs map to chromosome 12,
although only three SNPs on the chromosome support the same locus. These SNPs map
to the dog leukocyte antigen (DLA) complex in the centromeric region of the
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chromosome. The association of this region with PAA is consistent with the autoimmune
component of the disease. Previous work, we showed that pancreases from GSDs with
PAA have increased expression of DLA-88 (46). DLA-88 is the most highly polymorphic
class I locus of the DLA complex. DLA class II loci are associated with diabetes mellitus,
anal furunculosis, hypoadrenocorticism, necrotizing meningoencephalitis, and several
other autoimmune disorders of the dog (47-50). Canine systemic lupus erythematosus is
also reported to be associated with alleles of the DLA class II loci, and GWAS revealed
five additional associated loci (51,52). The current SNP data, together with previous
expression data, suggest that the DLA region may harbor a genetic risk factor for the
development of PAA. Further investigation of the DLA loci is planned. A second region
of interest is located on chromosome 7, which has four strongly associated SNPs located
within a 1.2 Mb region having 11 genes. None of these genes is known to be involved in
autoimmune disorders, although several are expressed in acinar cells.

The data reported here suggest that PAA may be governed by multiple loci with
small effects, or it may be a heterogeneous disorder. Although PAA was thought to be a
simple autosomal recessive disorder (53,54), the results of a recent test mating between
two GSDs with PAA indicate more complex genetic underpinnings (28). The study
monitored the cTLI scores for the resulting litter of six over the course of the dogs’ lives
(8–13 years) and the pancreas for each dog was examined at necropsy. Only two of the
six dogs in the litter were diagnosed with PAA (28). Similarly, the clinical presentation of
PAA is inconsistent. The age of onset is variable within families, with diagnoses made in
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puppies and adult dogs alike. The severity of clinical signs also varies, with some dogs
responding better to traditional treatment regimens than others. To further complicate the
matter, some GSDs never exhibit clinical signs, despite serum cTLI concentrations that
are diagnostic for EPI. Variability in age of onset and clinical signs may be an indicator
of genetic heterogeneity. Although PAA is the predominant cause of EPI in dogs, chronic
pancreatitis, pancreatic cancer, and other underlying medical conditions may also cause
EPI.

Variation between processed arrays, a so-called ‘‘batch effect,’’ can cause spurious
associations (55). The abundance of isolated SNPs detected in our GWAS for PAA is
suggestive of such artifacts. However, principal component analysis does not reveal
subpopulations that indicate a batch effect. Furthermore, no population stratification is
detected between PAA cases and controls (Supplementary Fig. 1). In addition, we
included only the robust ‘‘platinum’’ SNPs in our analysis to minimize artifacts from
incorrect genotype calls.

In this study, we used data from a single cohort of GSDs to identify major loci
associated with pituitary dwarfism, DM, and ME. Our data also reveal that the genetics
underlying PAA are highly complex. Candidate loci identified herein provide immediate
targets for future work.
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ABSTRACT
Araucana chickens are known for their rounded, tailless rumps and tufted ears.
Inheritance studies have shown that the rumpless (Rp) and ear-tufted (Et) loci each act in
an autosomal dominant fashion, segregate independently, and are associated with an
increased rate of embryonic mortality. To find genomic regions associated with Rp and
Et, we generated genome-wide SNP profiles for a diverse population of 60 Araucana
chickens using the 60K chicken SNP BeadChip. Genome-wide association studies using
40 rumpless and 11 tailed birds showed a strong association with rumpless on Gga 2 (Praw
= 2.45 x 10-10, Pgenome = 0.00575), and analysis of genotypes revealed a 2.14 Mb
haplotype shared by all rumpless birds. Within this haplotype, a 0.74 Mb critical interval
containing two Iroquois homeobox genes, Irx1 and Irx2, was unique to rumpless
Araucana chickens. Irx1 and Irx2 are central for developmental prepatterning, but neither
gene is known to have a role in mechanisms leading to caudal development. A second
genome-wide association analysis using 30 ear-tufted and 28 non-tufted birds revealed an
association with tufted on Gga 15 (Praw = 6.61 x 10-7, Pgenome = 0.0981). We identified a
0.58 Mb haplotype common to tufted birds and harboring 7 genes. Because
homozygosity for Et is nearly 100% lethal, we employed a heterozygosity mapping
approach to prioritize candidate gene selection. A 60 kb region heterozygous in all
Araucana chickens contains the complete coding sequence for TBX1 and partial sequence
for GNB1L. TBX1 is an important transcriptional regulator of embryonic development
and a key genetic determinant of human DiGeorge syndrome. Herein, we describe
localization of Rp and Et and identification of positional candidate genes.
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INTRODUCTION
There are hundreds of domestic chicken breeds worldwide (1). Breeds were
generally developed for meat and egg production, but morphological traits, plumage
color, and other distinctive characteristics were also selected. The Araucana chicken,
originally from Chile, is a multi-purpose breed initially established for its blue-shelled
eggs (1,2). Araucana chickens are also known for two other distinguishing traits: a
rounded, tailless rump and protruding ear-tufts. Although these traits segregate in the
population, the United States Araucana breed standard requires show birds to possess
both phenotypes.

The rumpless phenotype is characterized by the absence of all free caudal
vertebrae and the uropygial gland (3). Without underlying skeletal support, birds with
caudal truncation lack a fleshy rump and tail feathers (3). An intermediate rumpless
phenotype, wherein some caudal vertebrae are present but irregularly fused together, is
thought to result from a modifier gene introduced through crosses with non-Araucana
tailed chickens (3,4). The rumpless phenotype arises from a defect in caudal patterning
that is controlled by a dominant gene (Rp) (3). Rumpless Araucana chickens may be
heterozygous or homozygous for this locus. In test matings, all rumpless intermediates
were determined to be heterozygous (Rp/rp+) (3). Homozygosity is underrepresented
among chicks from rumpless to rumpless matings, indicating that the Rp/Rp genotype has
reduced viability (3,5). Birds having at least one copy of Rp have increased mortality in
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the embryo stage, with death occurring at 17 to 21 days of incubation (3). Rumpless birds
also have reduced fecundity as adults (3).

Ear-tufts are feather-covered, epidermal protrusions originating near the ear canal
(Fig. 1). The mass of tissue forming the protrusion, or peduncle, is believed to develop as
a result of the incomplete fusion of the hyomandibular arches, and it can vary in position
and length (from two mm to two cm) (6,7). Tufted chickens may also have structural
rearrangement of the ears (6). Abnormalities include irregularly shaped external ear
openings and shortened or absent external auditory canals (6).

Fig. 1. Araucana chicken. (a) General appearance of a rumpless, tufted Araucana chicken. (b) For
comparison, a tailed, non-tufted Araucana chicken.
doi:10.1371/journal.pone.0040974.g001
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Inheritance studies indicate that tufted is governed by a dominant locus, Et (6,8).
Test matings show that all tufted birds are heterozygous (Et/et+) and that homozygosity
for Et is lethal at about 17-19 days of incubation (6,8). Lethality among a portion of
heterozygous birds is also reported, appearing to occur at 20-21 days of incubation (8).
Post-hatch mortality is significantly higher among tufted chickens (6,8).

Because tufts can occur unilaterally or bilaterally and may differ in size from one
side to the other, Et is proposed to have variable expressivity (6). In addition, a paucity of
tufted progeny from mating studies in 1978 suggests reduced penetrance of the tufted
locus (6). In 1981, Somes and Pabilonia identified a tufted male that produced excessive
tufted progeny when crossed with an et+/et+ White Leghorn (86%), and they speculated
that Et/Et birds may occasionally reach maturity (8). The non-tufted chicks from the Et/Et
male produced tufted progeny when crossed with an et+/et+ White Leghorn, indicating
that their predicted genotype does not match their phenotype, providing further evidence
for variable penetrance.

The aim of our investigation was to localize the genetic bases for the rumpless
and tufted phenotypes of the Araucana chicken. To this end, we generated genome-wide
SNP profiles for 60 Araucana chickens using the 60K chicken SNP BeadChip (9). Using
a genome-wide association approach, we elucidate the chromosomal regions harboring
Rp and Et and identify strong candidate genes for each trait.
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RESULTS
Case/control analyses were carried out using 40 rumpless and 11 tailed Araucana
chickens (Fig. 2a). Seven birds described as having partial tails by their breeders were
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Fig. 2. Genome-wide association for Rp and Et. After 100,000 permutations, the genome-wide adjusted
P values (2log10 Pgenome) for each SNP are plotted by chromosome (left). The raw P values for the most
strongly associated chromosomes are plotted against chromosomal position (right). (a,b) 40 rumpless
versus 11 tailed Araucana chickens (c,d) 30 tufted versus 28 non-tufted Araucana chickens.
doi:10.1371/journal.pone.0040974.g002
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excluded from the rumpless association analysis because of uncertainty concerning their
phenotype. A total of 191 SNPs were associated with the rumpless phenotype (Praw ≤
0.0001), 72 of which were located on Gga 2 (Fig. 2b). The most significant result
obtained was for SNP Gga_rs13637596, located on chromosome 2 at position 88.95 Mb
(Praw = 2.45 x 10-10, Pgenome = 0.00575). The next two most significant results were for
proximal SNPs located at 89.17 Mb (Praw = 1.20 x 10-9, Pgenome = 0.0119) and 89.19 Mb
(Praw = 1.20 x 10-9, Pgenome = 0.0119).

Analysis of genotypes in the Gga 2 region revealed a 2.14 Mb haplotype (87.99 –
90.13 Mb) predicted to contain five genes (Fig. 3). All 40 rumpless birds had at least one
copy of the haplotype: 18 were homozygous and 22 were heterozygous. Partial tailed
birds were heterozygous. The haplotype was absent in its entirety from the 11 tailed
birds. Three tailed birds were heterozygous for partial blocks of the haplotype and further
delimit the critical interval to 0.74 Mb (88.77 - 89.51 Mb). This region contains two
candidate genes: Irx1 and Irx2.
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Fig. 3. Localization of Rp. Physical map showing the relative positions of mapped genes and
informative SNP markers within the 2.14 Mb rumpless haplotype on Gga 2. Light blue shading denotes
the rumpless haplotype (alleles are shown in the top row). Dashed lines flank the critical interval
wherein no tailed birds share the rumpless haplotype.
doi:10.1371/journal.pone.0040974.g003

Analyses for association with the tufted phenotype, using 30 cases and 28
controls, resulted in 31 significant SNPs, 11 of which map to Gga 15 (Fig. 2c). The most
significant results were for SNPs Gga_rs10730189 (Praw = 6.61 x 10-7, Pgenome = 0.0981)
and Gga_rs15762547 (Praw = 9.19 x 10-7, Pgenome = 0.118), located at positions 1.33 Mb
and 1.30 Mb on chromosome 15, respectively. Four other proximal SNPs also reached
significance (Fig. 2d).

Analysis of genotypes reveals that 29 of 30 tufted birds shared a haplotype
extending from the telomere of Gga 15 to position 1.75 Mb. These birds were
heterozygous for the complete haplotype. Two of 28 non-tufted birds were also
heterozygous for the haplotype in its entirety. A single tufted bird shared only part of the
1.75 Mb haplotype, defining a 0.58 Mb (0.90 – 1.48 Mb) critical interval that is
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heterozygous in all 30 tufted birds and contains 7 genes. Because tufted is nearly always
recessive lethal, blocks of homozygosity for the tufted haplotype were identified to
reduce the number of candidate genes. Homozygosity blocks in three birds flank a 60 kb
interval harboring two genes: TBX1 and GNB1L (Fig. 4).
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Fig. 4. Localization of Et. Physical map showing the relative positions of genes and informative SNP
markers in the associated region of Gga 15. Alleles of the tufted haplotype and positions are shown.
Pale green bars denote heterozygosity for the tufted haplotype. Black bars denote homozygosity for the
tufted haplotype. Dashed lines mark a 60 kb interval wherein all tufted birds are heterozygous for the
haplotype.
doi:10.1371/journal.pone.0040974.g004
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DISCUSSION
In this study, we used genome-wide SNP profiles to localize genes causative for
two breed-defining phenotypes of Araucana chickens, rumpless and ear-tufts. We took
advantage of the fact that both traits segregate independently in the population by using a
single data set to carry out an association analysis for each trait. Haplotype analyses
based on inheritance patterns were used to identify positional candidate genes for both
traits.

We identified a rumpless haplotype spanning 2.14 Mb and five genes on
chromosome 2. The haplotype is present in the heterozygous or homozygous state in
rumpless birds. All 7 birds with partial tails are heterozygous for the rumpless haplotype
and likely represent the intermediate phenotype described by Dunn and Landauer (3).
Because rumpless is dominant and fully penetrant, we further delimited the critical
interval by identifying regions of the haplotype shared by tailed birds. A 0.74 Mb region
common to all rumpless birds, and absent from 11 tailed birds, harbors Rp.

These data reveal that Rp maps to a region of Gga 2 that is distinct from the
predicted location of genes previously associated with caudal truncation (10-14). The
0.74 Mb critical interval contains the Iroquois homeobox genes, Irx1 and Irx2. The
Iroquois genes encode transcription factors that function in patterning and regionalization
of tissues early in development (15). Irx1 and Irx2 are prepattern and proneural genes
first identified in Drosophila and Xenopus (16,17). Studies of gene function suggest that
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Irx genes have redundant yet distinct roles in development (18,19). Irx genes have been
knocked out in mice and zebrafish with little effect on tail development (19-23).
However, the rumpless phenotype is dominant, suggesting that misexpression of Irx1 or
Irx2 may underlie the trait, rather than loss of function.

We identified SNPs on Gga 15 that are strongly associated with the tufted
phenotype and define a 0.58 Mb haplotype for which all tufted birds in our cohort are
heterozygous. No birds are homozygous for the complete tufted haplotype. These data
support conclusions from previous inheritance studies that suggest nearly 100% of tufted
birds are heterozygous, and that Et/Et is lethal (6,8).

Two non-tufted Araucana chickens are heterozygous for the tufted haplotype.
These birds may signify reduced penetrance. Penetrance of the tufted allele is estimated
to range from 86% to 96% (6,8). Based on the assigned phenotypes and the associated
haplotype, we observed 94% penetrance in our cohort. Alternatively, these birds may
have been incorrectly phenotyped by their breeders due to short peduncles or missing
protruding feathers.

The 0.58 Mb haplotype harbors 7 protein-coding genes. Unlike rumpless,
identification of the tufted haplotype in non-tufted birds could not be used to narrow the
critical interval because of reduced penetrance. However, because homozygosity for Et is
nearly always lethal, we were able to prioritize candidate gene selection using
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heterozygosity mapping. Tufted birds with blocks of homozygosity extending into the
0.58 Mb common haplotype were identified, and these regions were deemed less likely to
harbor the Et locus. These data indicate that Et is located in a region containing partial
coding sequence for GNB1L, which encodes a protein implicated in neuropsychiatric
disorders (24,25), and complete coding sequence for TBX1 (26), an important
transcriptional regulator of embryonic development.

Haploinsufficiency for TBX1 is considered to be the key genetic determinant of
human DiGeorge syndrome (DGS), which is caused by a heterozygous chromosomal
deletion of 22q11.2 (27). While the clinical phenotype is highly variable, DGS is
characterized by craniofacial and cardiovascular abnormalities. Malformations in DGS
are attributed to disturbed segmentation and patterning of the pharyngeal structures (28).
Auricular defects common in DGS include narrow or absent external ear canal and
protruding ears (29). Homozygosity for null mutations of TBX1 in mice and zebrafish
causes a range of phenotypic effects similar to DGS, including abnormal ear development
(30,31). Based on phenotypic similarities between the malformations causing ear tufts
and DGS, TBX1 is a highly plausible candidate gene and the primary focus of ongoing
work to identify the genetic basis for ear-tufts in Araucana chickens.

In conclusion, we used genome-wide association and haplotype analyses to
localize Rp and Et to chicken chromosomes 2 and 15, respectively. In addition, we
identified candidate genes that are immediate targets for future work.
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MATERIALS AND METHODS
Ethics Statement
This study was approved by the Clemson University IACUC protocol number
2011-041 and IBC protocol number 2010-041.

Study Cohort
Whole blood for DNA was collected from 6 different flocks of Araucana chickens
from the United States. Phenotypic information and photographs, when available, were
provided by owners. Birds with tufts of any size and on either side of the head were
classified as tufted. Because both traits segregate in the Araucana population, birds were
selected to ensure that the phenotypes were balanced. Our study cohort comprised 60
Araucana chickens: 21 rumpless/tufted birds, 20 rumpless/non-tufted birds, 7 tailed/nontufted birds, five tailed/tufted birds, five partial/tufted birds, and two partial/non-tufted
birds. Genomic DNA was isolated using the DNeasy blood and tissue kit (QIAGEN,
Valencia, USA) and adjusted to a concentration of 50 ng/µL.

Genome-wide Association Mapping
SNP genotypes were generated using the Illumina 60K chicken SNP BeadChip,
which has 57,636 SNPs across chromosomes 1 through 28, Z, W, and two unmapped
linkage groups (9). BeadChips were processed by DNA Landmarks (Quebec, Canada),
according to manufacturer’s protocols. Raw data files were analyzed using
GenomeStudio’s Genotyping Module to generate SNP calls. The PLINK Input Report
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Plug-in v2.1.1 was used to format the data. For analysis, Gga 27, Gga 28, Gga Z, Gga W,
and microchromosomes were all identified as chromosome zero. Case/control analyses
using 56,685 SNPs were performed using PLINK (32). Two birds with excessive missing
data were excluded from all analyses. By convention, Praw values ≤ 0.0001 were
considered significant. Permutation testing, using 100,000 iterations, was carried out
using PLINK.
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ABSTRACT
Canine familial dermatomyositis (DM) is a spontaneous inflammatory myopathy
that predominantly affects the collie and Shetland sheepdog breeds. DM is characterized
by painful lesions on the face and extremities; and, is similar clinically, histologically,
and immunologically to human juvenile dermatomyositis (human DM). The population
structure of dogs makes them an excellent model for the study of complex hereditary
diseases and DM in collie and Shetland sheepdogs is the only animal model described to
date. To find genomic regions associated with DM, we generated genome-wide SNP
profiles for a diverse population of 47 collies using the Illumina Canine HD BeadChip.
Genome-wide association studies using 17 DM-affected and 14 healthy control collies
showed a single, strong association with DM on CFA 10 (Praw = 1.97x10-6), and analysis
of genotypes revealed a 10.5 Mb haplotype shared by all DM-affected collies. Currently,
there are only five mapped genes in this region of the canine reference genome; however,
based on conservation of synteny with human chromosome 12, this region could contain
as many as 130 genes. Herein, we describe the localization of DM and discuss positional
candidate genes having a role in immune function.
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INTRODUCTION
Juvenile dermatomyositis (human DM) is the most common childhood
inflammatory myopathy, comprising about 85% of all diagnosed cases of inflammatory
myopathy (1,2). Human DM, which affects 3.2 children per million between the ages of 2
and 17 in the United States (with similar numbers in the United Kingdom), is a
vasculopathy that causes a characteristic skin rash and debilitating muscle weakness (35). The current method of diagnosis is based on a criterion and classification system that
was proposed in 1975 (6,7). In diagnosing human DM, the Bohan and Peter system
considers five major criteria, which are muscle involvement in the trunk with or without
respiratory involvement, signs of severe inflammation in muscle biopsy, elevated levels
of muscle enzymes in the blood, myopathy diagnosed via electrocardiogram, and
characteristic dermatologic involvement. Definitive diagnosis requires the presence of
three criteria in addition to dermatologic signs; probable diagnosis requires two criteria in
addition to dermatologic signs, while possible diagnosis requires one criterion in addition
to dermatologic signs (6,7). Early diagnosis and proper treatment of the disease are
important for improving the prognosis for an affected child (8). Calcinosis, abnormal
calcium deposits in various tissues, has been seen in patients with a long history of
undiagnosed disease, inadequate therapy, or chronic disease (9,10). Unfortunately, even
with well-defined criteria, a diagnosis of human DM can be hindered by the variety of
symptoms of a patient’s initial presentation (8). Once diagnosed, treatment with
corticosteroids and/or immunosuppressive drugs is necessary for remission or to prevent
further deterioration (8,9,11-13). The prognosis for a child with human DM is positively
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correlated with a quick diagnosis and proper treatment (9). The impact of human DM on
the life of a patient varies, but many children continue to have chronic flare-ups and/or
suffer from the chronic rashes, lesions, and muscle weakness (8). The etiology of DM is
not known, but DM is thought to be an autoimmune disease brought on by infection with
a virus or other agent (14-17). In one study, 71% of human DM patients had a clinical
history consistent with an infection prior to initial signs of human DM (18). There may be
a gene or multiple genes that predispose a patient to the condition (19).

Canine familial dermatomyositis (DM) is a naturally occurring autoimmune
disease of domestic dogs that is similar in clinical presentation to human DM. DM is
characterized by an inflammatory response in the skin and muscle tissue, typically around
the face, paws, and tail. The disease phenotype is highly variable, with signs ranging
from a mild, transient presentation to a near fatal presentation. Clinical findings
consistent with DM include the development of skin lesions such as hair loss, redness,
scaling and crusting on the face, ears, legs, and tail tip. Dogs afflicted with DM often
develop disfiguring scars and secondary skin infections. In severe cases, inflammation
affects muscle tissue and can cause muscle atrophy, megaesophagus, aspiration
pneumonia, and difficulty eating or walking. Muscle involvement can cause a poor
quality of life and owners often elect for euthanasia. Unfortunately, there is no cure for
DM and clinical signs may reoccur. Onset of DM ranges from two months to several
years of age. A dog may have produced multiple litters before the onset of clinical signs,
making it difficult for breeders to control disease transmission. Current treatment for DM
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includes the management of clinical signs, such as severe pain and secondary skin
infections. A twice-daily dose of the drug Pentoxifylline, which increases blood
circulation, is also recommended (20).

The diagnosis of DM is made by a veterinary histopathologist using skin punch
biopsies of actively afflicted tissue. All three layers of skin (dermis, epidermis, and
subcutis) are evaluated for signs of inflammation (Dr. J. Mansell, personal
communication). Some characteristic signs of DM include vacuolar alteration and
dilation of the basal cell layer in the epidermis, signs of apoptosis, and sparse superficial
perivascular lymphocytic infiltrates. When these and other cell changes are observed,
then a diagnosis of DM is made (Dr. J. Mansell, personal communication).

Two breeds with the highest prevalence of DM are collies and Shetland
sheepdogs (Shelties). DM has been diagnosed and characterized in both breeds since
1983 (21-23). These two herding breeds share a recent common ancestor (24) and likely
share the same original mutation contributing to DM. The exact prevalence of DM is
unknown, but affected dogs have been found in different breeding lines across the United
States. Data from two studies suggest that the inheritance pattern of DM is autosomal
dominant (21, Sherry Lindsey, personal communication). Hargis and colleagues, (21)
outcrossed an affected male purebred collie and an unaffected female purebred Labrador
retriever. Three of the four offspring developed clinical signs of DM that were milder
than those seen in offspring from an inbred litter. The inbred litter was a cross of the
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aforementioned collie sire and an affected female purebred collie. In an unpublished
study, two DM-affected purebred Shelties were bred and produced a single puppy that
never developed clinical signs of DM (Sherry Lindsey, personal communication).

Genome-wide association studies (GWAS) have been successfully used to
identify simple and complex traits of the dog (25,26). The goal of this work is to identify
a genetic region(s) of association with DM, utilizing GWAS.

MATERIALS AND METHODS
Sample Collection
Local and national collie breeders and collie rescues were contacted by electronic
methods to solicit research subjects. Whole blood or buccal cells were collected from
participants by their regular veterinarians. DM-affected collies were required to have a
histopathology report from a skin punch biopsy with a positive or differential diagnosis
of DM. Pedigrees from DM affected collies were collected when available. Control
collies were required to be at least seven years of age or older because, while variable, the
onset of DM usually occurs prior to 6 years of age. Participants had to be pedigreed,
without history of a dermatologic condition, and unrelated to any DM affected or control
collies within three generations.
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Genome-wide Association Mapping
Genomic DNA was isolated using the DNeasy blood and tissue kit (QIAGEN,
Valencia, USA) and adjusted to a concentration of 100 ng/µL. Illumina CanineHD
Infinium BeadChips were used to profile 173,662 SNP genotypes per collie, across
autosomal chromosomes 1 through 38 and sex chromosomes 39/X and 40/Y. BeadChips
were processed at the Cornell University Life Sciences Core Laboratories Center (Ithaca,
New York, USA) according to manufacturer’s protocols. Raw data files were analyzed
using GenomeStudio’s Genotyping Module to generate SNP calls. The PLINK Input
Report Plug-in v2.1.1 was used to format the data. Case/control analyses were conducted
with PLINK (27). By convention, Praw values ≤ 0.0001 were considered significant. R
(28) was used to generate Manhattan plots from the –log10 of the Praw value for each SNP.
Permutation testing, using 100,000 iterations, was carried out using PLINK. BeadChip
SNP positions were remapped to canFam3.

RESULTS
Our study cohort consisted of 27 DM-affected (ten females/17 males) and 20 (12
females/eight males) healthy collies. The age of DM-affected collies ranged from three
months to 11 years (at the time of sampling), while control dogs were seven to 12 years
of age. All blood and buccal samples were obtained from the United States, except for a
single DM-affected collie residing in Australia (no American ancestors in X #
generations). There was no significant difference in the distribution of males and females
in this study (p= 0.1476). We were unable to obtain information regarding the severity of
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the clinical signs of DM in all cases.

A principal components analysis using all 173,662 SNPs identified five collies that
did not cluster with the majority of the population, indicating a level of population
stratification from the remaining collies (Fig. 1). These five were considered outliers, one
control and four DM-affected collies, and were excluded from further analyses. The
remaining 42 dogs showed no evidence for population stratification.

To demonstrate the utility of the assembled cohort, a positive control was mapped
using GWAS. Hair length in dogs is determined by mutations in FGF5 on chromosome
32 (29). Smooth in collies refers to a short hair length, which is dominant to rough (long)
hair. Case/control analyses for eight smooth (six DM-affected/two controls) vs 33 rough
(15 DM-affected/18 controls) collies were carried out (Fig. 2). The most significantly
associated SNP was BICF2G630600757 on chromosome 32 (Praw = 4.70 x 10-12), and it
is located approximately 180 kb downstream from FGF5.
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Fig. 1. Principal component analysis of the collie cohort shows 42 dogs clustering together and five
outliers. The x-axis is principal component 1 and the y-axis is principal component 2.
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Fig. 2. Manhattan plot showing the results for GWAS for smooth using 173,662 SNPs. The genomewide P values (-log10 p) for each SNP are plotted against position on each chromosome. Eight smooth
collies versus 33 rough collies show a strong association on chromosome 32. The significance threshold
for this plot is -log10 (p) = 4.

Two DM-affected collies for which the diagnosis was questionable were excluded
from the DM analyses. Case/control analyses were carried out using 21 DM-affected and
19 healthy collies (Fig. 3A). A total of 88 SNPs were significantly associated with DM
(Praw ≤0.0001), 71 of which were located at the centromeric end of chromosome 10 (Fig.
4). The most significant results obtained were for five SNPs between 2.1 Mb and 2.9 Mb
on chromosome 10 (Praw = 2.23 x 10-7). Permutation testing using 100,000 iterations was
carried out to reduce any false positive results and the SNPs on chromosome 10 remained
most significant (Pgenome = 0.01373). Analysis of genotypes in the chromosome 10
region revealed a 10.5 Mb haplotype for which all DM-affected collies had at least one
copy (12 homozygous, nine heterozygous). The haplotype was also present in 74% of
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healthy collies (two homozygous, 12 heterozygous). There are more than 100 genes in
this 10.5 Mb region.

Fig 3. Manhattan plots showing the results for GWAS for DM using 173,662 SNPs. The genome-wide
P values (-log 10 p) for each SNP are plotted against position on each chromosome. A. Twenty-one DMaffected collies versus 19 healthy collies show a strong association on chromosome 10. B. After
balancing phenotypes, 17 DM-affected collies versus 14 healthy collies still show a strong association
on chromosome 10.
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Fig. 4. Scatter plot showing SNP positions along chromosome 10. The raw P values for the most
strongly associated chromosomes are plotted against chromosomal position for 21 DM-affected collies
versus 19 healthy collies. The significance threshold for this plot is -log10 (p) = 4.

Of the genes located in this associated DM haplotype, one has a known visible
phenotype, SILV. This gene is causative for merle coat patterning, a phenotype that
segregates in our cohort (30). Merle is autosomal dominant, but dogs having shortened
versions of the mutation do not show the merle phenotype (termed cryptic merles). To
determine the merle genotype, a direct mutation test was performed for all collies in our
study cohort. One DM-affected collie and six healthy controls were determined to be
merle, which is a significant difference in distribution (p=0.04). One merle healthy
control did not exhibit the phenotype. To identify the SNPs associated with merle, a
GWAS was performed using seven merle and 35 non-merle collies. A total of 141 SNPs
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were significantly associated with merle (Praw ≤0.0001), 103 of which were located at the
centromeric end of chromosome 10. Sixty-five SNPs on chromosome 10 were most
significant with a p-value of 6.45x10-10. This region is located 2.8 Mb downstream from
SILV. The five most significant SNPs for DM were not significantly associated with
merle (Praw=0.003123).

To confirm that our DM results are not an artifact of association with the nonmerle allele in our DM-affected population, the two populations were balanced for merle
and a second GWAS was conducted. Five merle collies were removed from healthy
control group, leaving one merle dog in each population. Additionally, both populations
were balanced for the smooth phenotype. Case/control analyses were rerun for 17 DMaffected (five females/12 males) and 14 controls (eight females/six males) (Fig. 3B).
Fifty-six of 68 SNPs significantly associated with DM were on chromosome 10. The
eight SNPs most significantly associated with DM were on chromosome 10 between 2.1
Mb and 2.5 Mb (Praw=1.97x10-6). These SNPs were within the haplotype previously
identified for DM. There are no mapped genes within this region. Two DM-affected
collies were heterozygous for a region defined by the top ten most significant SNPs,
while all other DM-affected collies were homozygous. Four SNPs on chromosomes 31,
32, and 39 also reached significance (Praw ≤0.0001).

DISCUSSION
In this study, we assembled a cohort of DM-affected and senior, healthy control
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collies for which we generated whole-genome SNP profiles for the study of DM. With
these data, we accurately mapped two coat traits that segregate in our cohort: smooth fur
and the merle coat pattern. Analyses to identify genes contributing to DM revealed a
primary region of association at the centromeric end of chromosome 10. Associated
SNPs span a 10.47 Mb region, and a 10.54 Mb haplotype is common to all affected dogs.
The haplotype is larger because it spans from the top of chromosome 10, where there are
no SNPs present on the array. The 70 kb region at the top of chromosome 10 can not be
excluded because the first SNP on chromosome 10 is within the haplotype for DM and
there are no markers upstream to break the haplotype.

Breeding studies have shown DM to be inherited in an autosomal dominant fashion
(21). Data generated herein support the hypothesis of an autosomal dominant mode of
inheritance because all affected dogs carried either one or two copies of the associated
haplotype. There were no correlations between sex or age of onset of DM-affected collies
relative to zygosity in the associated region. The presence of the haplotype among
healthy controls suggests that the allele may have reduced penetrance. A secondary factor
such as an environmental trigger or genetic modifier may be necessary for development
of the disease. In human DM, the phenotype results from a combination of environmental
and genetic factors (31). Environmental triggers include exposure to toxicodendrons,
emotional stress (e.g., the birth of a sibling), and UV radiation (32).

In our study population, we observed an underrepresentation of merles among the
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affected collies relative to the controls. The associated region on chromosome 10
encompasses the merle locus, but our data support inheritance of the DM allele on the
non-merle chromosome and show that different loci are linked with the two traits.

The number of genes in the DM haplotype region includes five dog RefSeq genes
and approximately 130 human RefSeq genes (33,34). The human RefSeq genes are from
human chromosome 12 (34). The identified DM haplotype region shows conservation of
synteny with human chromosome 12. Several genes have a role in immune function and
could be considered candidate genes for DM. Among these are IL23A, which has been
shown to be upregulated in humans with DM (35), and other cytokines including IL22
and IL26. IFNG is also found in this region and has been studied in conjunction with
muscle fiber atrophy in DM patients (36). Other genes in this region are involved in the
formation of muscle fibers, MYL6, and tissue patterning of skin and nerves, GDF11.

To narrow the critical interval and reduce the number of candidate genes, future
studies will focus on DM in other breeds, primarily Shetland sheepdogs. Collies and
Shetland sheepdogs share a common ancestor in the early herding dog of Scotland and
have been interbred as recently as the 1950s. It is likely that they share the genetic basis
for DM. An across-breed approach will allow us to take advantage of the differences in
homogeneity that exists between the breeds (37). Specifically, by comparing the DM
haplotype region identified in affected collies to the same region in affected Shetland
sheepdogs will elucidate differences between the two breeds and refine the critical
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interval. Upon refinement of the critical interval, positional candidate genes will be
identified and investigated for candidate causal mutations.

In conclusion, we used genome-wide association and haplotype analysis to localize
DM in the collie to canine chromosome 10. There are 130 genes in this region and future
work will focus on an across-breed approach to narrow down the critical interval.
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ABSTRACT
Domestic dogs have been under artificial selection by humans for hundreds of
years. Canis lupus familiaris is unmatched in phenotypic diversity, compared to other
mammals, and is an excellent model for investigating the genetic basis of phenotypic
diversity, due to their various physiology, morphology, and behavior traits. We
resequenced the genome of five American collies to 113-fold coverage using Illumina
HiSeq paired-end sequencing. Trimmed and concordant reads were mapped to the canine
reference genome (Broad CanFam3.1), generated from a boxer. We identified more than
9.7 million single nucleotide polymorphisms (SNPs), which showed concordance rates
>98% with Illumina BeadChip SNP data. The predicted consequence of each SNP was
determined based on its position relative to mapped genes. We also identified 671,197
structural variants including deletions, insertions, inversions, tandem duplications, and
break points shared by all 5 collies, relative to the canine reference genome. Genetic
regions, with significantly reduced heterogeneity surrounding a gene(s) under strong
positive selection, were detected on 9 different chromosomes. Candidate genes for two
phenotypes (Irish spotting and dolichocephaly) fixed in the collie breed were identified.
Sequence data generated herein provide a resource for the identification of variants
responsible for morphological traits and heritable diseases of the collie.
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INTRODUCTION
The dog, Canis lupus familiaris, has been a best friend to mankind since their
domestication more than 14,000 years ago (1). Through artificial selection, man has
created more than 400 different pure breeding lines, each arising from a need for certain
attributes (2). Selected traits include behaviors like herding, guarding, hunting abilities,
and morphological features like body size, coat texture, and ear carriage. As a result, dogs
are the most phenotypically diverse species among mammals. Purebred dogs are
maintained through closed breeding populations. Levels of homogeneity within breeds
are very high, while levels between breeds is considerably lower (3). Human populations
have high rates of heterogeneity and thus require large numbers of individuals to map
hereditary disorders (4,5). For this reason, purebred dog populations offer great models
for the study of hereditary diseases in humans.

Because dog breeds exhibit as many as 340 naturally occurring analogous human
diseases (6), the NIH prioritized the dog genome for whole-genome sequencing. In 2005,
the first draft of the canine reference sequence was released: a 7.6 X coverage, highquality assembly generated for a female boxer (2). The estimated sequence length,
including gaps, is 2.5 Gb. Roughly 3% of the sequence assembly was highly repetitive
and could not be mapped (2). The reference genome covers more than 98% of the
euchromatic regions (2). This consortium also generated a dense SNP map, using 3
different cohorts, that consists of more than 2.5 million single nucleotide polymorphisms
(SNPs) (2). First, the consortium identified within the boxer sequence SNPs having a
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different allele on two or more unique reads (~770,000 SNPs). Second, they compared
the boxer draft sequence to the previously published 1.5 X standard poodle sequence
(~1,460,000 SNPs) (7). Third, shotgun sequence data for nine various dog breeds
(~100,000 reads each, 0.02-fold coverage), four grey wolves and one coyote (~22,000
reads each, 0.004-fold coverage) was aligned to the boxer (~440,000 SNPs). There have
been a total of three different versions (builds) of the canine reference genome. The first
build was assembled using a version of the ARACHNE program (8) and is referred to as
CanFam1.0; most of the initial quality analyses of the genome were based on this version
(2). A second build (CanFam2.0) is an updated assembly that was released in 2005 with
minimal improvements over CanFam1.0 (2). Currently, canine SNP arrays (Affymetrix
and Illumina brand) are based on the CanFam2.0 build of the reference genome. In 2012,
a third build was released (Broad CanFam3.1) with improvements including: an N50 (the
measure of a majority of the contig lengths in an assembly, 9) ~1.5 times longer, ~8,000
fewer contigs, and an 8-fold reduction of assembled sequence in gaps (10). The size of
the canine reference genome in Broad CanFam3.1 is 2.4 Gb (2).

New methods of whole-genome sequencing technologies were introduced in the
beginning of the 21st century that allowed for massive parallelization. This highthroughput method, termed next-generation sequencing (NGS), greatly reduced the cost
and time for generating data. Illumina’s HiSeq technology simultaneously sequences
millions of shorter read fragments (11). These short reads can be mapped back to a
reference genome, but are not ideal for generating a de novo assembly sequence because
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of the high incidence of misassembling regions containing repeats and the high
redundancy of the short reads (12).

The whole-genome sequencing projects of three dog breeds have been published,
a 1.5X coverage of the poodle, a 7.6X coverage of the Boxer, and a 45X coverage of the
Korean Jindo (poodle, boxer, Korean Jindo references). Herein, we resequenced the
complete genomes of 5 collies and mapped the data to the CanFam3.1 build of the canine
reference genome. We identified SNPs and structural variants (insertions, deletions,
tandem duplications, inversions, and breakpoints) present in the collie and not the boxer.
We also verified concordance of the SNPs identified in the whole-genome resequencing
by running Illumina Canine HD BeadChip arrays on the same collies. We then classified
the effect of the genetic variants we identified (13). Furthermore, we identified 9
chromosomes with regions of reduced heterogeneity and propose two candidate genes for
selection in the collie.

MATERIALS AND METHODS
Sample Collection
Collie owners were contacted via electronic methods to solicit research
participants. Pedigrees, information regarding age, sex, coat color, and hair length, and
medical histories were collected from purebred American collies. Whole blood for DNA
was collected by the primary care veterinarian of each dog. In order to maximize data
gleaned from the genome sequences, pedigrees were used to select the five most
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genetically diverse American collies. Two dogs shared a common ancestor in the fourth
generation while no common ancestors were present in the first six generations of the
others. Among the dogs selected for sequencing were males and females, roughs and
smooths, and solids and blue merles (Table 1).

Whole-genome sequencing
Genomic DNA was isolated using the DNeasy blood and tissue kit (QIAGEN,
Valencia, USA) and adjusted to a concentration of 50 ng/µL in 10mM Tris-CL buffer pH
8.5, measured by optical density using a NanoDrop 1000 Spectrophotometer (Thermo
Scientific, Wilmington, USA). One hundred fifty ng of DNA was used for 2x100 bp
paired-end sequencing, on an Illumina HiSeq 2000 at the University of Missouri DNA
Core Facility (Columbia, Missouri, USA). Two compressed fastq files were generated per
lane containing each end of the pair.

Data preparation
The quality of each set of reads was examined using FastQC v0.10.1 (14).
Trimming and sorting of all reads was conducted using Trimmomatic v0.30 (15). The
output of forward and reverse, paired and unpaired reads were re-examined to verify an
improvement of quality. Some of the metrics used to assess quality include: improvement
in the per base sequence quality, the per sequence quality scores, the absence of
overrepresented sequences, and low kmer content (15).
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The Broad CanFam3.1 “soft-masked” assembly sequence (2) was downloaded
from the UCSC Genome Bioinformatics site (13) and formatted for indexing in Bowtie2
v2.1.0 (16). “Soft-masked” refers to the representation of repeat sequences as capital
letters and all other sequences as lower case letters. Bowtie2 was used to align all paired
forward and reverse reads per lane to the Broad CanFam3.1 genome. SAMtools v0.1.18
(17) was used to convert the Bowtie2 output alignments for sorting and indexing.
Interactive Genomics Viewer v2.3 was used to visualize the results (18,19).

DATA ANALYSIS
Coverage, single nucleotide polymorphism and structural variant discovery
GenomeCoverageBed (2009), a part of the bedTools suite v 2.16.2 (20), was used
to generate data in order to calculate the average sequence coverage for each collie. A
variant call file (VCF) v4.1 combining all five collies was produced using SAMtools (17)
and BCFtools (17).

The sorted and indexed result files for all five collies were used as input to Pindel
v0.2.4t (21) and structural variants (deletions, inversions, tandem duplications, short
insertions, long insertions, and unassigned breakpoints) relative to the reference genome
were detected. Structural variants present in all five collies were identified.
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The Variant Effect Predictor script release 73 by Ensembl (22) was run on our
complete VCF containing data from all five collies to categorize the location and/or type
of amino acid or splice site change predicted by each SNP.

Selective sweeps
To identify selective sweeps, we implemented the creeping window method
described by Qanbari et al. (23). We identified all SNPs in our whole-genome sequence,
outside of “soft-masked” regions, and used a window size no larger than 1 Mb. We
ignored gaps of greater than 10 kb between SNPs. If a creeping window had 50 or fewer
SNPs, then it was not considered in our data set. The heterozygosity (Hp) statistic was
calculated for all creeping windows. All Hp values were averaged and the standard
deviation was calculated. Each Hp value was Z-transformed, making the average Hp
value 0 and the standard deviation equal to 1.

Concordance rate between whole-genome sequence and Illumina arrays
Genomic DNA from each collie was adjusted to a concentration of 100 ng/µL.
Illumina CanineHD Infinium BeadChips were used to profile 173,662 SNP genotypes per
collie, across autosomal chromosomes 1 through 38 and sex chromosomes 39/X and
40/Y. The BeadChips were processed at the Cornell University Life Sciences Core
Laboratories Center (Ithaca, New York, USA) according to manufacturer’s protocols.
Raw data files were analyzed using GenomeStudio’s (2011.1) Genotyping Module v1.9
to generate SNP calls. The PLINK Input Report Plug-in v2.1.1 was used to format the

127

data. BeadChip SNP positions were remapped to the Broad CanFam3.1 using the UCSC
Genome Browser’s LiftOver script (24) to determine the concordance rate with the
whole-genome resequence data. Array SNPs with missing data were dropped from the
comparison.

RESULTS
Study Cohort
In order to identify the most genetically diverse collies for whole-genome
sequencing, pedigrees were analyzed to determine relationships. Five genetically diverse
American collies were selected. Two dogs shared a common ancestor in the fourth
generation with no common ancestors present in the first six generations amongst the
others. Among the dogs selected for sequencing were males and females, roughs and

Collie

Sex

Coat Type

Coat Pattern

Age at
Collection
(years)

Inherited
Autoimmune
Disease

smooths, and solids and blue merles (Table 1).

1
2
3
4
5

M
F
M
M
F

Smooth
Rough
Rough
Rough
Rough

Solid
Merle
Merle
Solid
Solid

1
10
9
<1
7

Yes
No
No
Yes
Yes

Table 1. Collies selected for whole-genome sequencing.
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Whole-genome resequencing
Genomic DNA from five collies was sequenced using the Illumina HiSeq 2000
with individual paired-end libraries. The following fragments were gel size selected:
Collie 1 – 478 bp, Collie 2 – 530 bp, Collie 3 – 467 bp, Collie 4 – 526 bp and Collie 5 –
513 bp. The range of the pass filtering rate was from 75% - 93%. The number of reads
produced ranged from 531 to 997 million, providing roughly 48 to 75 Gb of sequence
(see Supplementary Table 1).

Sequence Analysis
Paired-end reads were trimmed for low quality scores in the leading 3 bp, trailing
6 bp, and within a sliding window of size 4 bp. Reads were eliminated if their minimum
length fell below 36 bp. Reads were mapped to the canine reference genome that was
“soft-masked” for repeats (Broad CanFam3.1/canFam3) using Bowtie2 with sensitive
parameters. Genome coverage ranged from 16.8 X – 24.9 X, resulting in a combined 113fold coverage.

SNP Detection
Putative SNPs were determined by comparing the reference sequence to the
aligned reads of all five collies. More than 9.7 million unique SNPs were identified
across the genome, including unmapped linkage groups. Genotype data from Illumina
Canine HD beadchips were used to validate a subset of the identified SNPs. A total of
167,692 SNPs were placed on the reference genome (11,740 SNPs from the SNP array
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could not be remapped to Broad CanFam3.1 and were discarded from further analysis).
Concordance rates ranged from 98% to over 99% between the BeadChip genotypes and
whole-genome resequencing genotypes (Table 2). While this method does not validate all
identified SNPs, the SNPs it does validate were identified as highly informative (25).

Collie 1
Collie 2
Collie 3
Collie 4
Collie 5

SNPs total
29,755
29,757
29,688
29,762
29,746

SNPs
same
29,656
29,647
29,201
29,675
29,642

SNPs different
99
110
487
87
104

SNPs NA
525
523
592
518
534

Concordance
99.67%
99.63%
98.36%
99.71%
99.65%

Table 2. Comparison of Illumina CanineHD BeadChip genotypes to sequencing SNPs. These results
indicate a low false positive rate of SNP discovery. NA genotypes result from missing results from either
method for a given SNP.

The Variant Effect Predictor, available through Ensembl, was used to assess and
categorize the location of all SNPs and small variations, compiled in the VCF file,
relative to mapped genes present on chromosomes 1 – 38 and X. SNPs were
characterized based on location (intergenic, intronic, upstream, downstream, splice site,
5’ UTR, or 3’ UTR) or type of change (frameshift, missense, synonymous, stop gained,
stop lost, stop retained, or within mature miRNA). Detailed results can be seen in Table
3.
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Table 3. SNP Functional class membership for collies. SNPs were identified by sequencing of five
collie genomes and grouped by predicted functional consequences. The percentage of SNPs in each
class are in the last column.

Structural Variants Detection
A total of 4,298,455 structural variants were detected using Pindel (21) including:
deletions, inversions, short insertions, tandem duplications, long insertions, and other
unassigned break points (Table 4). A total of 675,341 variants were found to exist in all
five collies across the genome, including unmapped linkage groups. The remaining 3.6
million structural variants were not common to all five collies.

131

/&$0#(
D.5&##%"(.F.G-&#".7"'&2".
GH.3'2044"1.#%':07".
7+&34(
5-+<
5-+E
5-+=
5-+@
5-+D
5-+A
5-+B
5-+>
5-+C
5-+<?
5-+<<
5-+<E
5-+<=
5-+<@
5-+<D
5-+<A
5-+<B
5-+<>
5-+<C
5-+E?
5-+E<
5-+EE
5-+E=
5-+E@
5-+ED
5-+EA
5-+EB
5-+E>
5-+EC
5-+=?
5-+=<
5-+=E
5-+==
5-+=@
5-+=D
5-+=A
5-+=B
5-+=>
5-+I
!"#$%

,-&+$.
/0'1"2.
6&'7.
8$-"+.9+"0:.
!"#"$%&'(
)'*"+(%&'( )'("+$%&'( !34#%50$%&' )'("+$%&'( ;&%'$(
<=>==<?
@A<B@
CDEAD?
<<?E<
CDEAD?
CDEAD?

!"#$%&'(
)*+,)--

=DBA@E

<BB<

EA?CBC

<DD@

=D==

@C>AE

./-0)1

<C?=B
<ED<=
<@DD=
<=C<B
<=BC?
<??EE
CCD@
<=<E>
>A>?
<<@EA
<?=BE
<@A>A
>E>?
>DC<
<<DDB
>ACE
C=DC
>B=@
CA@B
AC?B
B@B?
>A>?
>>AD
B@DB
CD<<
A<C>
AA@<
A<=?
>=<>
AA=B
A>CA
BCB=
D<@E
>C@C
D<>C
DA?E
DDEA
=>=@
A>CC
0--/.*

<?D
B<
A?
AD
D>
D=
@@
AE
AC
@D
@=
BD
@E
=<
D@
==
@>
@>
@<
=A
=D
=<
D<
=D
=B
DB
=E
=E
=B
=D
=B
=D
E@
@B
ED
=E
E>
EA
=B
1/-.

<=B?>
>A=?
<?AC<
CCAC
CB=<
B<>E
B=><
CD?B
A?>D
><DA
BD=A
<?B>E
A<@<
AA<>
>D>>
A@=E
AC<B
A<@C
BEAC
@BCB
D=@?
A@A>
A>B=
D=?A
B<=>
@=AA
@AC<
@=E=
A=B?
@CEC
DE?C
DCD=
=>?B
AAB?
=CEB
@E@=
@E=E
E><?
@B>=
*-+/2/

C<
A=
D=
DC
DA
@A
@<
DD
=@
DA
@>
A>
=?
=A
@<
=C
@C
DA
=@
EA
EC
EB
=?
=>
=?
EA
EC
E=
EC
E@
E?
=@
E@
==
E?
E?
E>
EE
@<
1-2,

E??
<D?
<EE
<EB
<E=
<?A
CC
<=>
B>
<<?
>>
<==
>?
B=
<<E
>B
>C
>C
>C
B<
A<
>?
>C
>=
CC
BE
DC
DC
BD
D>
A?
A<
@B
>=
A<
D=
=C
=>
CB
0)0,

=?B<
<>B@
<>@C
<A@@
E<>@
<B?<
<=BB
<>?=
<A>B
<>=@
<=>=
<B<?
<?AC
CD<
<DB=
<<=@
<=?E
<=<E
<?B=
<=<?
<?@D
<?=C
<?A<
<<<>
<<BD
CCC
C?B
C=@
C??
CAD
BBA
B?>
ABA
<?D?
A=D
A==
><>
DC<
<<DD
)+2*.

0.*1*
*0021
*/0*,
*-/,1
*-+)*
1+112
1,,+.
*).+0
1..00
*1.*/
1+)/2
*/)-)
1-.)*
1.022
*1+*1.)1/
1//.)
1.0,,
1,1-0
101)/
10+,2
1.0*1.+.+
1)20/
1/++2
11/1,
1*0-+
11-21
1-/*+
1*.),
1*++,
1)/.)
+/*2
1.,0*
+,-/
12-,0
12./1
/0*1
1021*
./11+/

Table 4. Results from Pindel analyses. All deletions, inversions, short insertions, tandem duplications,
long insertions, and other break points were identified across the reference genome and existing in all
five sequenced collies. Totals include all mapped chromosomes and linkage groups, as well as all
chromosomes individually.
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We identified 671,197 structural variants on chromosomes 1 – 38 and X that were present
in all five collies. The remaining 4,144 variants were found in the unmapped linkage
groups.

There were 355,762 deletions shared by all five collies. Deletions varied in length
from one to 32,787 bp, with the average being 40 bp and the median deletion being two
bp. There were 1,756 inversions between one and 32,887 bp long; the average and
median inversion of 16,897 bp. Tandem duplications varied from 29 to 32,776 bp, with
an average and median of 22,160 bp. A total of 259,707 short insertions varied from one
to 77 bp in length and had an average and median of one bp.

Selective Sweep Discovery
We identified regions of pooled heterozygosity (Hp), in order to detect signals of
recent selection. Z-transformation of the Hp values resulted in a mean value of 0 and a
standard deviation of 1. The negative ZHp distribution was plotted to show putatively
selected regions greater than 3.4 standard deviations from the mean (Fig. 1). A region
with significantly reduced heterogeneity, surrounding a gene(s) being selected for, is
called a selective sweep. Based on our data, we hypothesize the existence of selective
sweeps on chromosomes 1, 5, 8, 10, 12, 15, 24, 29, and 34. The SNPs used to demarcate
the regions were not part of repeat regions.
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Fig. 1. The negative tail of the ZH p distribution presented along autosomes 1-38. The X chromosome was not included because
the sex of the five collies was not considered. Each dot represents a creeping window of up to 1 Mb. The horizontal blue line
stands for the significance level at ZHp = -3.4.

DISCUSSION
In this study, we used an Illumina HiSeq 2000 sequencer and paired-end reads to
obtain mapped genome sequence of the collie. The high coverage sequence data
generated herein provides a novel resource for future studies in the breed. Previous work
from our laboratory indicated that SNPs identified from the canine reference sequence
project were largely uninformative in collies, presenting a challenge for the mapping of
phenotypes. In addition to SNPs, our data revealed 671,197 structural variants (deletions,
insertions, inversions, tandem duplications, and break points) present in all 5 collies.

We identified over 9.7 million SNPs relative to the canine reference genome. This
number is comparable to that reported by a recent dog resequencing project that reported
more than 4.6 million SNPs detected from a single male dog (28). The high number of
SNPs observed in the single Korean Jindo dog, compared this study of five collie dogs,
may be explained by the Korean Jindo breed being more divergent from the boxer or by
mapping error in the Korean Jindo’s aligned sequence (28). Further indication that the
collie exhibits increased homozygosity is provided by a large number of chromosomes
having possible selective sweeps. A total of 9 chromosomes whose loss of heterozygosity
would indicate fixation of long stretches of DNA were identified.

Two chromosomes, CFA12 and 15, were of specific interest because they harbor
dog leukocyte antigen (DLA) genes and KITLG, respectively. The significant reduction
of heterogeneity surrounding these genes suggests the presence of selective sweeps. DLA
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is important in immune recognition and regulation (29,30). KITLG encodes the ligand of
the tyrosine-kinase receptor and harbors mutations in other species that affect
melanogenesis (31). All collies are fixed for a coat pattern termed Irish spotting, which is
characterized by a white collar around the neck, white feet, and a white tail tip. Although
no coding mutations were detected in KITLG, two 200-300 bp deletions in the 5’ region
are homozygous in all five collies and will be further investigated as candidate mutations
for Irish spotting.

A selective sweep on CFA 24 encompasses BMP7, a gene important in skeletal
patterning (32). Bone and cartilage result from the transformation of mesenchymal cells
with a protein encoded by BMP7. This gene may be involved in the head morphology of
collies, characterized by distinct dolichocephaly – extremely long muzzles relative to the
width of their heads. Other chromosomes displayed comparable levels of sweeps and
analysis of these regions is ongoing.

A large number of structural variants (deletions, insertions, tandem repeats,
inversions, and unassigned breakpoints) were observed among the collie genomes. The
length of some variants was extremely long, and further investigation of individual
variants revealed the presence of false positives. Because the software, Pindel (21),
analyzing the data had no threshold set regarding a minimum number of reads, if only
one read in each of the collies matched the variant, then it was called. This shortcoming
was most notable among the deletion class of variants. Several extremely large deletions
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were present in all five dogs, but were not supported by a majority of the reads in the
regions. Without the support of approximately 50% of the total reads per dog, these
deletions are erroneous. Future work should include additional analyses to increase the
stringency of read thresholds.

The very high concordance rates between the whole-genome resequencing data
and the BeadChips confirm that both data sets are high-quality. By extension, the
unvalidated SNPs are considered to be of the same quality. Of the whole-genome
resequencing SNPs that were discarded, 13 were from the Y chromosome, which is not
covered by the canine reference sequence. The variant predictor software by Ensembl
identified any functional effect changes resulting from SNPs identified in the collie
genome. While many SNPs were predicted to result in missense, nonsense, and
frameshift mutations, these data are based on predicted coding regions and do not account
for unmapped genes or errors in the annotation. The investigation and validation of these
variants is beyond the scope of this study.
In conclusion, we generated 113X coverage resequencing data of the collie
genome. Additional data are necessary to determine the significance of the structural
variants and the selective sweeps identified herein.
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CHAPTER VII
CONCLUSIONS

SUMMARY
Next-generation sequencing (NGS) technology has helped with the construction
of de novo genome sequences and the mapping of other genomes, using reference
sequences (1-6). In addition, NGS has enhanced the ability to gather the following
genome-wide sequence information: explaining phenotypes by sequencing genotypes,
identifying polymorphisms, mapping mutations, and identifying noncoding RNA (7).
Whole-genome sequencing is a thorough way to investigate a genome; however, single
nucleotide polymorphisms (SNPs) and BeadChip arrays use information from a
previously sequenced genome to interrogate a genome more quickly and affordably by
using genome-wide association studies (GWASs).

GWASs have been used successfully within and across breeds to identify loci and
mutations underlying diseases, physical characteristics, and behavioral traits of dogs (8–
16). When using this approach, two important factors that must be accounted for are
population stratification and kinship within the affected and control individuals (17). For
the work presented here, we collected unrelated dogs and chickens for our GWASs and
whole-genome resequencing (12,18). In addition, we conducted principal components
analysis to detect population stratification (15). GWASs have allowed our laboratory to
study more quickly diseases and other phenotypic traits in the dog.
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OBJECTIVES
The goals of the work presented here were as follows: Chapter II - identify the
genetic mutation that causes the autosomal recessive disease episodic falling syndrome
(EFS) in the Cavalier King Charles Spaniel. Chapter III - identify loci associated with
four diseases (pituitary dwarfism, degenerative myelopathy, congenital megaesophagous
(ME), and pancreatic acinar atrophy (PAA)) in the German shepherd dog. Chapter IV identify the loci associated with the tailless and ear-tuft phenotypes in the Araucana
chicken. Chapter V - identify loci associated with dermatomyositis (DM) in the collie.
Chapter VI - generate whole-genome resequencing data for the collie in order to annotate
single nucleotide polymorphisms (SNPs), insertions, deletions, inversions, tandem
duplications, break points, and selective sweeps present in the breed relative to the
reference genome.

EPISODIC FALLING SYNDROME IN CAVALIER KING CHARLES SPANIELS
Chapter II reports that a 15.7 kb deletion in the BCAN gene causes EFS in the
Cavalier King Charles Spaniel (12). Preliminary studies indicated that EFS is inherited in
an autosomal recessive fashion, suggesting that relatively few individuals could be used
to identify the associated locus. A GWAS, using Affymetrix Canine V2 SNP arrays data
from 12 individuals (five affected and seven control) and Sanger sequencing of positional
candidate genes, allowed for the discovery of this mutation (12). The 12 study dogs came
from the USA, New Zealand, and the UK. Additional testing of unrelated American
Cavalier King Charles Spaniels revealed a 12.9% carrier rate, making the mutation more
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common than expected (12). Finally, the use of the developed direct mutation test will
allow breeders to identify carriers and prevent litters with affected puppies (12).

MULTIPLE DISEASES IN THE GERMAN SHEPHERD DOG
A single data set was interrogated for association with both simple and complex
diseases in Chapter III. Affymetrix arrays were used to generate SNP profiles for 197
German shepherd dogs, segregating multiple phenotypes. A GWAS for autosomal
recessive pituitary dwarfism used 4 affected and 193 normal-sized German shepherd
dogs. Association was detected with a locus on chromosome 9, which included a strong
candidate gene, LHX3 (15).

Degenerative myelopathy is inherited in an autosomal recessive pattern with
incomplete penetrance. Significantly associated SNPs proximal to the causative gene,
SOD1, were identified along with other unlinked loci, suggesting the presence of
modifying loci (15). Awano et al. (8) identified a missense mutation in SOD1 in German
shepherd dogs and other breeds as the causative mutation.

ME was thought to be a simple recessive trait, but despite a large population (19
affected and 177 control), a predominant association was not detected (15). ME was
associated with a 4.7 Mb haplotype of SNPs on chromosome 12 present in all affected
German shepherd dog but also in 46% of the control dogs (15). These results support an
autosomal recessive pattern with incomplete penetrance.
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PAA is a complex, autoimmune disorder. GWAS, using 100 affected and 79
controls, showed significant associations throughout the genome, suggesting either the
presence of multiple loci with small effects or that PAA may be a heterogeneous disorder
(15).

RUMPLESSNESS AND EAR-TUFTS IN ARAUCANA CHICKENS
In Chapter IV, SNP data generated using an Illumina platform was utilized to identify
loci associated with two traits of the Araucana chicken. Mapping for the rumpless (Rp)
and ear-tuft (Et) phenotypes in the Araucana chicken revealed associations on
chromosome 2 and 15, respectively (18). Rp is associated with a 2.14 Mb haplotype,
which includes a critical region of 0.74 Mb having two homeobox genes: Irx1 and Irx2
(18). Et is associated with a 0.58 Mb haplotype in all tufted chickens (18). Because
previous inheritance studies indicate that the trait is homozygous lethal, a 60 kb region
for which all tufted chickens are heterozygous was identified and harbors the complete
coding region of TBX1, a plausible candidate gene (18).

Whole-genome resequencing data for the Araucana chicken was generated to
investigate the associated regions on chromosomes 2 and 15. Unfortunately, there were
multiple sequencing gaps within both regions. These regions have high GC content,
requiring special protocols. Future experiments will need to be carried out in order to fill
in these gaps and to identify the mutations causing the traits.
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DERMATOMYOSITIS IN THE COLLIE
The genetic basis for DM, an inherited autoimmune disease, was investigated in
the collie in Chapter V. The pattern of inheritance for DM was previously reported to be
autosomal dominant (19). GWAS identified a genetic region of association on canine
chromosome 10, and we identified a 10.5 Mb haplotype present in all affected collies
(nine heterozygous and 12 homozygous). This region on canine chromosome 10 shares
conservation of synteny with human chromosome 12, which harbors approximately 130
genes.

Collies and Shetland sheepdogs share a common ancestor in the early herding dog
of Scotland and have been interbred as recently as the 1950s. As a result, both likely
share a founding mutation for DM. Using an across-breed approach allows us to take
advantage of the differences in homogeneity that exists between the breeds (16). An
across-breed study using Shetland sheepdogs will be carried out in the future in order to
refine this 10.5 Mb region, and identify positional candidate gene(s).

MAPPING THE COLLIE GENOME
Chapter VI describes the whole-genome resequencing of the genomes of five
collies. A 113-fold coverage of the collie genome was produced, and over 9.7 million
SNPs were identified; 671,197 structural variants (deletions, insertions, inversions,
tandem duplications, and break points) were found in all 5 collies. Additionally, the
identification of selective sweeps indicates recent losses in heterozygosity on the
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following chromosomes: 1, 5, 8, 10, 12, 15, 24, 29, and 34. Initial analyses identified
genes on chromosomes 12 (MHC genes), 15 (KITLG), and 24 (BMP7) that may underlie
traits fixed in the collie. In addition to validating the existing data, further analyses on
copy-number variation will be performed. Furthermore, data generated herein will be
used to identify candidate causal mutations for canine DM.

IMPACT
In conclusion, this work provides further validation that whole-genome SNP data
can be used to identify SNPs and haplotypes associated with phenotypes. NGS
technologies provide an affordable means by which to identify additional SNPs and
structural variants specific to a population or an individual. When combined, these tools
provide a powerful method for the dissection of heritable traits in dog and chicken.
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Appendix B
Supplementary Information for Chapter 3

Supplementary Fig. 1 Principal component analysis of 98 GSDs with PAA versus 79 healthy control
GSDs. The x axis is principal component 1 and the y axis is principal component 2. Both populations
appear to be evenly distributed throughout the cluster and no significant stratification was observed
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Supplementary Table 1: Uncorrected and corrected P values (PAA) are shown for the
50 SNPs with significant Praw values (P<0.0001). Corrected P values are from 100,000
permutations (EMP2 or Pgenome) and the Benjamini-Hochberg test (FDR_BH).
SNP
chr35.4925078
chr12.58146406
chr28.32676786
chr12.23177472
chr33.30105637
chr15.40294695
chr7.82831339
chr5.51353689
chr3.76398656
chr33.25987767
chr1.9328042
chr24.31358922
chr37.12660891
chr9.10239350
chr6.39598998
chr13.30418286
chr10.13435580
chr35.19780099
chr28.13143663
chr4.13107661
chr4.4080795
chr14.54484895
chr23.14905565
chr17.44088133
chr5.68085129
chr2.86073514
chr12.12567352
chr10.68614890
chr3.93468384
chr12.27205596
chr12.3781476
chr7.12305239
chr28.38709005
chr26.20243802

Praw
1.59E-11
9.28E-11
9.59E-11
1.48E-10
1.85E-10
3.03E-10
2.43E-09
3.44E-09
3.85E-09
5.02E-09
1.18E-08
1.77E-08
3.69E-08
4.07E-08
2.80E-07
3.16E-07
3.24E-07
3.67E-07
4.73E-07
7.54E-07
8.72E-07
9.10E-07
9.67E-07
1.47E-06
1.94E-06
1.98E-06
4.83E-06
5.75E-06
5.89E-06
6.76E-06
8.88E-06
1.16E-05
1.41E-05
1.49E-05
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EMP2
2.00E-05
2.00E-05
2.00E-05
2.00E-05
2.00E-05
2.00E-05
0.00026
0.00035
0.00039
0.00043
0.00083
0.00115
0.00225
0.00244
0.01431
0.01574
0.01598
0.01791
0.02195
0.03298
0.03707
0.03814
0.04017
0.05733
0.0711
0.07227
0.1536
0.1737
0.1771
0.1981
0.2478
0.2998
0.3461
0.3599

FDR_BH
6.43E-07
1.30E-06
1.30E-06
1.50E-06
1.50E-06
2.05E-06
1.40E-05
1.73E-05
1.73E-05
2.03E-05
4.36E-05
5.97E-05
0.0001149
0.0001177
0.0007564
0.0007722
0.0007722
0.0008268
0.001009
0.001527
0.001675
0.001675
0.001703
0.002474
0.003082
0.003082
0.007242
0.008223
0.008223
0.009124
0.01161
0.01469
0.01731
0.01778

chr12.4698937
chr9.54243104
chr7.5792722
chr2.18072233
chr3.29459535
chr7.11222056
chr6.33280800
chr12.3845215
chr7.12424701
chrX.87975142
chr6.18214638
chr17.5088861
chr7.12310223
chr31.36637612
chr17.52274900
chr5.3236960

1.73E-05
1.86E-05
2.79E-05
3.26E-05
3.47E-05
3.53E-05
4.06E-05
4.72E-05
4.92E-05
5.00E-05
5.42E-05
6.64E-05
6.75E-05
8.75E-05
9.12E-05
9.98E-05
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0.3985
0.4241
0.5349
0.5823
0.6062
0.6125
0.655
0.7004
0.7151
0.7203
0.7426
0.8006
0.808
0.8689
0.8774
0.898

0.01999
0.02098
0.03059
0.03474
0.03574
0.03574
0.04011
0.04552
0.046
0.046
0.04881
0.0582
0.0582
0.07383
0.07542
0.08084
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Data type

Lib name

No. of reads

Illumina PE
Illumina PE
Total

Collie 1
Collie 1
Collie 1

364,699,442
371,255,612
735,955,054

Read
Length
(bp)
100
100
100

Fragment
length
Yield (Mb) Coverage
(bp)
478
33,075
478
33,606
478
66,681
24.3

Illumina PE
Illumina PE
Total

Collie 2
Collie 2
Collie 2

487,373,242
484,341,294
971,714,536

100
100
100

530
530
530

38,941
38,937
77,878

25.1

Illumina PE
Illumina PE
Total

Collie 3
Collie 3
Collie 3

264,861,662
266,131,024
530,992,686

100
100
100

467
467
467

24,184
24,309
48,493

16.8

Illumina PE
Illumina PE
Total

Collie 4
Collie 4
Collie 4

308,226,036
308,759,182
616,985,218

100
100
100

526
526
526

28,558
28,613
57,171

21.9

Illumina PE
Illumina PE
Total

Collie 5
Collie 5
Collie 5

500,770,100
495,968,940
996,739,040

100
100
100

513
513
513

37,595
37,173
74,768

24.9

Supplementary Table. 1 Sequence data from 5 collies, 2 lanes of data per collie.
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